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Drosophila JIL-1 kinase mediates histone H3 SerlO phosphorylation, maintains higher order 
chromatin structure, and is implicated in dosage compensation 
Yanming Wang 
Major Professors: Kristen M. Johansen and J0rgen Johansen 
Iowa State University 
The Drosophila JIL-1 tandem Ser/Thr kinase is associated with chromosomes/ 
chromatin throughout the cell cycle in early embryos and localized to hundreds of sites on 
the open interband regions on third instar larvae polytene chromosomes. Interestingly, the 
level of JIL-1 is upregulated on the male X chromosome, which is hypertranscribed for 
dosage compensation. The distribution of JIL-1 overlaps with that of MSL (male specific 
lethal) proteins and JIL-1 is associated with the MSL complex. 
To further study the function of JIL-1 in vivo, a series of JIL-1 mutants from 
hypomorphs to null were generated. Analyzing the phenotypes of JIL-1 mutants, we found 
that JIL-1 is required for the viability of both females and males. Moreover, in the surviving 
flies of JIL-1 hypomorphic mutants, the number of males is less than that of females, 
implicating that JIL-1 plays a role in dosage compensation. JIL-1 is also required during 
early embryonic development and for the maintenance of normal higher order polytene 
chromosome structure in third instar larvae. 
2 
Our studies also showed that JIL-1 is involved in the histone H3 SerlO 
phosphorylation signaling pathway. The JIL-1 immunocomplex can phosphorylate the SerlO 
site in a synthetic H3 N-terminal peptide in vitro. In vivo, SerlO phosphorylation levels in the 
third instar larvae of JIL-1 mutants are dramatically reduced. In addition, the decreased H3 
SerlO phosphorylation level can be restored with a GFP-JIL-1 transgene. Moreover, the 
phosphorylated H3 SerlO is elevated and colocalized with JLL-1 on the male X chromosome. 
Thus, our data suggest a model whereby JIL-1 is involved in a signaling pathway that 
regulates histone H3 SerlO phosphorylation in D. melanogaster, which is required to 
maintain the appropriate higher order chromatin structure to facilitate chromatin functions, 
such as gene expression, dosage compensation, and so on. 
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CHAPTER 1. INTRODUCTION 
Organization of this dissertation 
This dissertation begins with background information about the JIL-1 project: what is 
known about the molecular properties and in vivo distribution of JIL-1, and the putative 
involvement of JIL-1 in the dosage compensation pathway. This background information is 
the important starting point for my study. Following the background, questions raised, tested, 
and discussed in this dissertation are listed together with a brief description of the research 
approaches applied to address these questions. 
Chapter 2 is a literature review. The abundance of literature related to chromatin 
structure and function, which was utilized during this study to design experiments to better 
understand the function of JIL-1, cannot all be included within the confines of this chapter. 
Therefore, literature related to chromatin structure, the modification of chromatin structure 
by ATP-dependent chromatin remodeling complexes, and the covalent histone modification 
enzymes is discussed. In addition, examples of how the above mentioned activities are 
coordinated with the general transcription machinery are shortly summarized. Last, dosage 
compensation related studies are reexamined with emphasis given to the Drosophila system. 
Chapter 3 describes the experimental materials and methods used in this study. 
Chapter 4 presents results and discussion emphasizing the work that I have been 
primarily involved with during my study. If the work was mainly done by another person, the 
name of that person is referred to. One thing I want to address here is that all of the beautiful 
confocal imaging of fluorescent labeled samples was done by Dr. J0rgen Johansen, which 
will not be noted again in the following text. 
Chapter 5 is general conclusions of these studies. 
References cited in this dissertation are listed together at the end. 
Background of JIL-1 
The JIL-1 kinase was identified using mAb 2A to screen a Xgtl 1 genomic expression 
library of Drosophila. The mAb 2A stains a dynamically changing nuclear structure during 
the cell cycle (Johansen, 1996; Johansen et al., 1996). A partial DNA sequence screened 
from this library was used to screen other libraries to get the full length cDNA. The JIL-1 
cDNA encodes a protein of 1207 amino acids including two Ser/Thr kinase domains (Hanks 
et al., 1988). Whereas the KDI (kinase domain I) of JIL-1 is highly conserved showing 
striking homology with members of the MSK/RSK subfamilies, the KDII (kinase domain II) 
is quite diversified from other kinase domains (Fig 1). Noteworthy is that JIL-1 contains a 
long N-terminal domain and a long C-terminal domain that are not found in MSKs and RSKs 
(Johansen et al., 1999). 
The in vivo distribution study of JIL-1, which utilized a GFP tagged JIL-1 (GFP-JIL-
1) transgene and immunostaining of various fly tissues with JIL-1 antibody, found that JIL-1 
is widely distributed in many tissues at different developmental stages and is associated with 
chromatin/chromosomes (Jin et al., 1999). In early embryos, the GFP-JIL-1 signal was found 
to be associated with chromatin/chromosomes throughout the cell cycle (Fig 2C). In the 
developing egg chambers of ovaries, GFP-JIL-1 was found in the diploid nuclei of follicle 
cells and formed fibrous structures in the polyploid nurse cell nuclei (Fig 2A, B). The nurse 
cell nucleus is a place where active transcription occurs and all of the maternal mRNAs 
required for the early embryo development are produced. Taking advantage of the huge 
larval polytene chromosomes in the salivary gland of third instar larvae, immunostaining 
with JIL-1 antibodies indicated JIL-1 is distributed along hundreds of bands on all of the 
female polytene chromosomes, while it is upregulated on the dosage compensated male X 
chromosome marked by hyperacetylated H4K16 (H4Acl6) (Fig 3; Jin et al, 1999; Turner et 
al., 1992; for dosage compensation, see literature review). Furthermore, the staining pattern 
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Fig 1. JIL-1 is a tandem Ser/Thr kinase that belongs to the MSK subfamily. (A) The JIL-1 
kinase has two kinase domains with the conserved features of Ser/Thr kinase (Hanks et 
al., 1988). The KDI (kinase domain I) of JIL-1 shares 63% and 47% identity with human 
MSK-1 and D. melanogaster RSK, respectively, while the KDII (kinase domain fl) of 
JIL-1 has only 32% and 28% identity with its MSK-1 and RSK counterpart. (B) 
Phylogenetic analysis to study the relationship of JIL-1 and its homologs. A consensus 
maximum parsimony tree generated from the sequences of the KDI of JIL-1 and its 
closely related homologs demonstrated JIL-1 and MSK form a subfamily that is separate 
from and yet closely related to the RSK kinase subfamily. The yeast PKC was used as an 
outgroup for constructing the tree (modified from Johansen et al., 1999). 
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Fig 2. GFP-JIL-1 is associated with chromosomes/chromatin throughout the cell cycle. 
(A) GFP-JIL-1 was found in the nuclei of diploid follicle cells and polyploid nurse cells 
in the developing fly ovary egg chambers. (B) GFP-JIL-1 forms a fibrous network in a 
nurse cell nucleus. (C) GFP-JIL-1 is associated with the chromosomes throughout the cell 
cycle in the early embryos (modified from Jin et al., 1999). 
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Fig 3. Localization of JIL-1 on the larval polytene chromosomes. (A, B, and C) JIL-1 
antibody stains hundreds of bands that correspond to the interband regions of all of the 
female chromosomes. (A) JIL-1 was found to form hundreds of bands on all arms of the 
female polytene chromosomes. (B) The same polytene chromosome as shown in (A) was 
stained with Hoechst to visualize the condensed band regions. (C) In this composite 
figure, there is little overlap between the JIL-1 antibody staining and the Hoechst DNA 
staining, suggesting JIL-1 is preferentially localized to the open interband regions. (D and 
E) The level of JIL-1 protein, as indicated by antibody staining, is greatly elevated on the 
male X chromosome compared with that on the autosomes. (F and G) The bands stained 
by JIL-1 on the male X chromosome are largely excluded from the bands of Hoechst 
staining. Noticeable is the weak staining pattern of the male X by Hoechst (F), 
demonstrating the open chromosome configuration of the male X (modified from Jin et 
al., 1999). 
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of JIL-1 is largely excluded from that of the DNA dye Hoechst, which stains the more 
condensed band regions on polytene chromosomes. This would indicate that JIL-1 is 
localized to the open interband regions on the polytene chromosomes. 
The staining pattern of JIL-1 on the male X is reminiscent of that of MSL (male 
specific lethal) dosage compensation proteins. Double labeling of polytene chromosomes 
with both JIL-1 antibody and antibodies against members of the MSL dosage compensation 
complex showed that JIL-1 colocalizes with the MSL proteins on the male X chromosome 
(Fig 4; Jin et al., 2000). Furthermore, when MSL complex is ectopically recruited to the 
female X chromosomes, more JIL-1 is recruited onto the female X chromosome, hence the 
level of JIL-1 on the MSL bound female X chromosome is also upregulated, suggesting the 
elevated level of JIL-1 on the male X is due to the function of the MSL complex (Jin et al., 
2000). 
Protein phosphorylation plays a fundamental role in various cellular signal 
transduction pathways, such as cell growth, cell differentiation, cell division, and gene 
expression (Hunter, 2000). The finding that JIL-1, a putative Ser/Thr protein kinase, is 
colocalized with the MSL proteins and upregulated on the male X suggests that protein 
phosphorylation may also play a role in the dosage compensation pathway. 
In addition to its elevated male X distribution, JIL-1 is also distributed on autosomes 
in males and is evenly distributed on all of the chromosome arms in females, suggesting a 
more general role for JIL-1 in addition to its possible role in dosage compensation. The 
association of JIL-1 with chromosomes in the early embryos and in the nuclei of the nurse 
cells and follicle cells in the developing egg chambers hints that JIL-1 could play some roles 
in other developmental processes. 
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Fig 4. The JIL-1 staining pattern overlaps with that of MSL and H4Acl6 staining. (A, B, 
and C) Double labeling of the same polytene chromosome with anti-JIL-1 antibody and 
anti-acetylated H4-Lysl6 (H4Acl6) antibody. JIL-1 was found to colocalize with the 
H4Acl6 isoform at most sites, as shown in the composite (A) with predominant yellow 
signals. (D, E, and F) Double labeling with JIL-1 and MSL1 antibodies showed JIL-1 
staining overlaps with that of MSL1 on the male X chromosome. MSL-3 and JIL-1 
double labeling also showed overlapping staining patterns (G, H and I). The arrowheads 
in (A, D, and G) point out that JIL-1 is localized to telomere regions where MSL staining 
is excluded (modified from Jin et al., 2000). 
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Research questions 
Bearing the previous studies of JIL-1 in mind, I set up a series of experiments to 
answer the following questions: 
1. What is the substrate of the JIL-1 kinase? 
To reach this end, I have tried to express and purify JIL-1 in E. coli. After finding that the 
E. coli expressed JIL-1 is kinase inactive, I switched to in vitro immunocomplex kinase 
assays to test various putative substrates. After the finding of loss of function JIL-1 mutants, 
the phosphorylation level of putative substrate was analyzed with phosphorylation and 
sequence specific antibody developed for the substrate. 
2. Is there a physical interaction between JIL-1 and members of the MSL complex? 
To address this question, I have used the V5 mAb against the JIL-1-V5 fusion protein 
expressed in the Drosophila Schneider 2 (S2) cells and affinity purified anti-MSL antibodies 
to carry out co-immunoprecipitation experiments to study protein-protein interactions. In 
addition, the GST-JIL-1 fusion proteins expressed in E. coli were used for in vitro pull down 
experiments to further study these putative interactions and map the interacting region(s) of 
JIL-1 with the MSL complex. 
3. What are the JIL-1 mutant phenotypes and how do these mutant phenotypes reflect the 
function(s) of JIL-1? This question can be divided into several small questions: 
a. Is JIL-1 important for the viability of males, females or both? 
To answer this question, we requested a P-element insertion line, EP(3)3657 or EP3, in 
which an EP element was inserted into the first exon of JIL-1 locus, upstream of the starting 
methionine. This line turns out to be a hypomorph and JIL-1 expression is not totally 
blocked. Starting from this line, a stronger hypomorph Z60 and a null allele Z2 were 
generated using imprecise P-element excision methods. The excised part of the gene was 
mapped by PGR. The imprecise excision and PGR work were done by Dr. Kristen M. 
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Johansen and Weiguo Zhang. The importance of JIL-1 protein for the viability of both males 
and females was analyzed in these mutant strains. The number of males and the number of 
females of the surviving JIL-1 mutants were counted and compared to analyze the effect of 
loss of JIL-1 on the viability of males and females separately. 
b. Is JIL-1 important for regulating early embryonic development? 
Since JTL-1 is associated with chromosomes in the early embryos, we reasoned it might 
play a role in early embryo development. To address this question, early embryos produced 
by the homozygous EP(3)3657 parents were analyzed by Hoechst staining for DNA and 
tubulin staining for microtubules. 
c. Is JIL-1 important for maintaining polytene chromosome structure? 
Since JI1-1 can form hundreds of bands on the polytene chromosomes in the third instar 
larvae, we investigated what is the effect of loss of JIL-1 on polytene chromosomes by 
staining polytene chromosomes from EP(3)3657, Z60, and Z2 with Hoechst and MSL2 
antibody to study the chromosome structure. 
4. Is the in vivo phosphorylation of the in vitro identified putative substrate of JIL-1 
immunocomplex correlated with the function of JIL-1? 
To analyze the distribution of the phosphorylated isoform of the putative JIL-1 substrate, 
phosphorylation and sequence specific antibody and JIL-1 antibody were used for double 
labeling in larval polytene nuclei. In the JIL-1 loss of function mutants, the phosphorylation 
level of the putative substrate of the JIL-1 immunocomplex was studied by western blots 
with phosphorylation and sequence specific antibodies. 
5. Are there any other proteins that interact with JIL-1? 
To answer this question, I did two-hybrid screens with different portions of JIL-1 as bait. 
Two of the JIL-1 interacting candidates found in the two-hybrid screen were further analyzed 
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by double immunostaining and/or in vitro protein-protein interaction assays, such as 
coimmunoprecipitation, and GST-pull down. 
Taking together, the study of the questions raised above will help us to better 
understand the function of JIL-1. The results of these studies support a hypothesis that the 
JIL-1 kinase works in the histone H3 SerlO phosphorylation signal transduction pathway and 
is involved in the regulation of chromatin structure that putatively affects gene expression, 
such as dosage compensation, and other chromatin functions. 
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CHAPTER 2. LITERATURE REVIEW 
Chromatin structure and organization 
The basic unit of chromatin is the nucleosome, which is comprised of a histone 
octamer made up of an H3-H4 tetramer and two H2A-H2B heterodimers, organizing about 
200bp of DNA together with histone HI (Kornberg, 1974; Kornberg, 1999). Although the 
model of nucleosome organization was proposed in 1974, the high-resolution structure was 
not resolved until 23 years later (Luger et al., 1997). The X-ray structure of the nucleosome 
provides a structural basis to interpret the many processes that involve DNA and chromatin 
as a template, such as transcription, replication, recombination, condensation and 
segregation. In this crystal structure, the histone octamer forms the nucleosome core wrapped 
up by 1.7 turns of a left-handed DNA superhelix. Each histone protein contains a domain 
with three a helices, which forms the histone fold, and two unstructured tails. The interaction 
between the histone fold domains forms a handshake-like structure mediating the formation 
of the H2A-H2B heterodimer and the H3-H4 heterodimer. Two H3-H4 heterodimers are 
packed into a tetramer that is attached by an H2A-H2B dimer at each side to form the 
octamer. Approximate 121 bp of the 146bp DNA used in the nucleosome crystal are 
organized by the histone octamer with each heterodimer binding about 30bp of DNA (Luger 
et al., 1997). A remarkable feature of the nucleosome core structure is the ordered nature of 
the histone N-terminal tails and the involvement of these tails in nucleosome-nucleosome 
interaction (Rhodes, 1997). The histone tails protrude out from minor-groove channels of the 
DNA helix after every 20bp of DNA. A cluster of basic residues on the H4 tail contacts the 
acidic surface of an H2A-H2B dimer from a neighboring nucleosome, forming multiple 
hydrogen bonds and salt bridges. Although the N-terminal tails are very long, they do not 
form any secondary structure and only one-third of them are visible. This reported structure 
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offers many insights into how transcription is regulated and how protein factors interact with 
the nucleosome on the chromatin. 
Little is still known, however, about how nucleosomes are folded into higher order 
chromatin structure during interphase and further packed to form condensed metaphase 
chromosomes. Chromatin is dynamically folded and unfolded to accommodate transcription 
and DNA replication, while tightly packed to facilitate the faithful segregation of 
chromosomes into daughter cells (Hirano, 2000; Tumbar et al., 1999). Many multiple protein 
complexes involved in these processes have been identified, including covalent histone 
modification complexes, chromatin remodeling complexes, and chromatin condensation 
complexes. However, how these multiple-protein complexes regulate the dynamic folding 
and unfolding of chromatin is still poorly understood. 
The interphase chromatin can be divided into two categories, gene rich euchromatin 
and gene poor heterochromatin (Weiler and Wakimoto, 1995). Heterochromatin is condensed 
even in interphase, replicated later in S phase, and often found around centromeres or 
adjacent to telomeres. The DNA in heterochromatic regions is often highly repetitive satellite 
DNA and transposable elements with very few genes. There are approximately 40 
heterochromatic loci found in D. melanogaster, including the tandemly arrayed 18S and 28S 
rDNAs, the rolled!ERK-A MAP kinase gene, and some other genes (Weiler and Wakimoto, 
1995 and references therein). Although the heterochromatic environment is important for the 
expression of some heterochromatic genes, the rearrangement of euchromatic genes close to 
the heterochromatin regions often inhibits their expression. A well-known example of this 
phenomenon, called position effect variegation (PEV), occurs in Drosophilci. When the white 
gene is rearranged closely to the centromeric heterochromatin by chromosome breakage and 
rejoining, white gene expression is epigenetically turned on or turned off in fly eyes, 
suggesting the condensed heterochromatin is an expandable structure that is generally 
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repressive for transcription (Wallrath, 1998). Conversely, euchromatin is decondensed in 
interphase, replicated early in S phase, and contains most genes of the genome. The unfolded 
feature of euchromatin offers a favorable environment for transcription. However, a recent 
study found some regions of euchromatin can silence a miniwhite reporter gene in both sexes 
of D. melcinogaster (Kelly and Kuroda, 2001). In addition, when roxl, a non-coding RNA 
gene involved in the dosage compensation process, was placed adjacent to the silenced 
miniwhite reporter gene, the reporter gene expression demonstrated a variegated p he no type 
(see below for dosage compensation). However, whether these euchromatic silencing sites 
adopt a mechanism similar to that of heterochromatin, and how they are correlated with the 
interspersed band and interband regions along the length of chromosomes still need further 
study. 
Chromatin is also organized into compartments of distinct structure and function 
(Lamond and Eamshaw, 1998). In the interphase nuclei, chromosomes are organized into 
individual territories that are separated by interchromosomal channels (Huang, 1998). Active 
genes tend to be found at the surface of the chromosomal territories where transcription 
occurs, and RNA transcripts are released into the channels, processed, and transported out of 
the nucleus. This model predicts that regulation of the size of the chromosome surface and 
the dynamic redistribution of active and inactive genes in the territories are important for 
transcription regulation. Moreover, it seems that the position of chromatin in the nucleus 
correlates with the timing of DNA replication (Li et al., 1998; Ma et al., 1998; Wei et al., 
1998). In cultured Chinese hamster ovary cells, the early replicating DNA (R band) was 
found dispersed throughout the nuclear interior, whereas the late replicating DNA (G band) 
and heterochromatic DNA were found close to the nuclear periphery (Ma et al., 1998). 
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ATP dependent chromatin remodeling machinery 
It is proposed that the ground state of transcription in eukaryotic organisms is 
restrictive because of the organization of histones and DNA into nucleosomes (Kornberg and 
Lorch, 1999; Struhl, 1999). Electron cryomicroscopy studies offered direct imaging evidence 
that the nucleosome is a natural barrier to transcription and causes pausing of the RNA 
polymerase (Bednar et aL, 1999). Additionally, the access of protein factors to their DNA 
binding sites is spatially prohibited by the nucleosome. For example, nucleosomes were 
shown to prevent the binding of TBP (TATA binding protein) to the TATA element, 
therefore, the majority of yeast core promoters are not associated with TBP in the absence of 
functional activators (Kuras and Struhl, 1999). 
The organization of DNA into nucleosomes and chromatin raises the question of how 
the transcription machinery gains access to the DNA template. Genetic and biochemical 
studies in yeast, D. melanogaster, and human cells have identified a new class of multiple 
protein complexes that utilize ATP to remodel nucleosome and chromatin structure 
(Bjorklund et al., 1999; Trivier et al., 1996; Tyler and Kadonaga, 1999; Workman and 
Kingston, 1998). In D. melanogaster, four different ATP-dependent chromatin remodeling 
complexes have been identified. The Brahma complex is the fly counterpart of the yeast 
SWI/SNF complex, which contains more than 7 subunits including the BRM (Brahma) 
ATPase. The other three complexes, NuRF, ACF, and CHRAC, contain ISWI (imitation of 
switch") as the ATPase. The NuRF (nucleosome remodeling factor) complex remodels 
nucleosomes by promoting histone octamer sliding along the DNA (Hamiche et al., 1999; 
Mizuguchi et al., 1997). The ACF (ATP-utilizing chromatin assembly and remodeling factor) 
complex can change the internucleosomal spacing and modulate the nucleosomal 
configuration at the promoter regions. Working together with CAF-1 (chromatin assembly 
factor -1), the ACF complex can facilitate chromatin assembly in vitro in the presence of 
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ATP as well (Ito et al., 1997). The CHRAC (chromatin accessibility complex) was found to 
induce nucleosome sliding without dissociation from DNA (Langst et al., 1999). In general, 
these complexes promote the accessibility of DNA sites to protein factors, which would 
otherwise be blocked by the nucleosome. Members of the ATP-dependent chromatin 
complexes are evolutionary conserved among yeast, D. melanogaster, and human (Bjorklund 
et al., 1999; Tyler and Kadonaga, 1999). 
Mutagenesis studies of D. melanogaster ISWI, the ATPase subunit of the three 
chromatin-remodeling complexes (NURF, CHRAC, and ACF), revealed ISWI is important 
for both cell viability and gene expression during development. Mutations in ISWI caused 
structural changes in the male X chromosome, underscoring the function of ISWI in 
chromosome remodeling. Colocalization studies indicated the ISWI protein does not 
colocalize with RNA PolII, suggesting the ISWI protein is not directly involved in 
transcription (Deuring et al., 2000). 
Although chromatin remodeling complexes were originally identified as factors that 
promote gene activation, more recent studies indicated these complexes are also involved in 
transcription repression (Tyler and Kadonaga, 1999). A DNA microarray study of global 
gene expression in yeast revealed the SWI/SNF complex is important for not only gene 
expression but also gene repression (Holstege et al., 1998). The identification of proteins 
with chromatin remodeling activity and histone deacetylase in the NuRD (the nucleosome 
remodeling and deacetylation) complex suggests histone deacetylation, the histone 
modification related to repression, could be facilitated by nucleosome remodeling as well 
(Tong et al., 1998). In addition, BRGl and hBRM, the human homologs of SWI/SNF, can 
bind to the Retinoblastoma (Rb) protein and inhibit the activity of the transcription activator 
E2F (Muchardt and Yaniv, 1999). Perhaps whether activation or repression of gene 
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expression occurs depends on the protein factors that bind to the chromatin when the 
chromatin remodeling complex opens it up. 
Histone modifications that regulate chromatin structure and function 
It has long been known that certain residues of the histone tails can be modified by 
phosphorylation, acetylation, methylation, ADP-ribosylation, and/or ubiquitination (Strahl 
and Allis, 2000). These histone tail modifications were proposed to play a fundamental role 
in regulating and executing appropriate functions in response to extracellular stimuli (Cheung 
et al., 2000). Extensive studies in the recent literature demonstrated that the precise 
regulation of many DNA and chromatin involved processes, such as transcription, 
replication, recombination, condensation and segregation, depends on the appropriate histone 
modifications and compatible chromatin environment. 
The long and extended N-terminal histone tails are easily accessible to multiple 
protein factors, making them attractive substrates for modifications and good candidates for 
mediating protein and chromatin interaction (Luger et al., 1997). Although the function of 
these histone tails is still elusive, a common view is that histone tails might serve as a signal 
platform on which diverse enzymes add and erase modifying moieties, and to which multiple 
protein complexes are recruited and released according to what histone modification or 
combined histone modifications exist (Strahl and Allis, 2000). 
Compared with other kinds of histone modifications, histone acetylation is the most 
extensively studied (Strahl and Allis, 2000). The finding of HATA I (histone acetyl 
transferase A 1) in Tetrahymena and its yeast ho mo log, GCN5, ignited a series of studies of 
histone acetylation (Brownell et al., 1996). HATAI was identified using a SDS-
polyacrylamide gel electrophoresis based activity assay from Tetrahymena macronuclei 
where hyperacetylated histones are enriched and transcription takes place. In vivo, the HAT 
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activity of GCN5 was required for the expression of various genes in yeast (Kuo et al., 1998). 
Recent studies found that many components of the transcription complexes, such as the 
TAF„250 of the TFIID and P/CAF (P300/ÇBP associated factor), possess intrinsic histone 
acetyl transferase activity, suggesting histone acetylation is closely correlated with 
transcription (Mizzen et al., 1996; Yang et al., 1996). Using nuclear magnetic resonance 
(NMR) to study the solution structure of the bromodomain of P/CAF and its binding ligand, 
including histone tail peptides, the bromodomain was found to bind only to the lysine-
acetylated H3 and H4 peptides (Dhalluin et al., 1999). The bromodomain, a conserved 
sequence of about 100 amino acids, is found in many chromatin associated proteins, 
including many nuclear histone acetyltransferases (HATs). 
The study of histone modification was greatly facilitated by the development of site-
and modification-specific antibodies. Using antibodies against histone H4 isoforms 
acetylated at lysine 5, 8, 12, or 16, a pioneering study in Drosophila showed that acetylated 
lysine 5 and 8 isoforms are distributed throughout euchromatic arms, whereas the acetyl-
lysine 12 isoform is distributed to the B-heterochromatin in the chromocenter. Interestingly, 
the acetyl-lysine 16 isoform is associated with the transcriptionally hyperactive X 
chromosomes in male larvae (Turner et al., 1992). This work suggests that different 
acetylated H4 isoforms have unique and discrete effects on chromatin function. Further 
studies, applying these acetylation-specific antibodies on mammalian chromosomes, found 
the inactivated female X is hypoacetylated (Jeppesen and Turner, 1993). Recently, a series of 
phospho-, acetyl-, and methyl-histone site specific antibodies were developed and have 
already led to many important discoveries in histone modification studies (see below). 
The reversible protein phosphorylation controlled by protein kinases and 
phosphatases plays a fundamental role in many cascades of signal transduction (Hunter, 
2000). Not surprisingly, the phosphorylation of histone H3 at its basic N-terminal tail was 
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rapidly increased in response to growth factors, phorbol esters, okadiac acid, and protein 
synthesis inhibitors. The dynamics of histone phosphorylation are correlated with the 
transcriptional induction of proto-oncogenes, c-fos and c-jun, suggesting histone 
phosphorylation might play a role in gene expression as well (Mahadevan et al., 1991; 
Thomson et al., 1999b). The identification of RSK-2 (ribosomal S6 kinase -2) and MSK1 
(mitogen and stress activated kinase 1) and the discovery that these protein kinases are 
involved in histone H3 SerlO phosphorylation greatly forwarded the understanding of the 
histone H3 SerlO phosphorylation signal transduction pathways that lead to gene expression 
(Deak et al., 1998; New et al., 1999; Sassone-Corsi et al., 1999). That the JIL-l kinase is the 
closest homolog of human MSK1 in D. melanogaster makes it intriguing to investigate 
whether JIL-l could be involved in the SerlO phosphorylation pathway. Noteworthy is that 
RSK-2 mutations are associated with human Coffin-Lowry syndrome (Trivier et al., 1996). 
The fibroblasts from the Coffin-Lowry syndrome patient or RSK-2 knockout mice failed to 
phosphorylate H3 SerlO in response to EOF stimulus as indicated by staining with an 
antibody that specifically recognizes the phosphorylated H3 at SerlO. The lack of SerlO 
phosphorylation in these fibroblasts could be restored by an RSK-2 transgene (Sassone-Corsi 
et al., 1999), suggesting RSK-2 is required for the EGF induced H3 SerlO phosphorylation in 
vivo. Moreover, MSK1 can be activated by both mitogen and stress signals and was proposed 
to mediate H3 SerlO phosphorylation and hence lead to the expression of immediate early 
genes c-jun and c-fos (Thomson et al., 1999a; Thomson et al., 1999b). 
Is there any crosstalk or coordination between the phosphorylation pathway and 
acetylation pathway if both of them are involved in the regulation of chromatin structure and 
transcription? Several studies indicated that phosphorylation and acetylation are 
synergistically regulated during the induction of c-fos and c-jun gene expression by EGF 
(Cheung et al., 2000b; Clayton et al., 2000). Using an antibody that is specific to H3 
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phosphorylated at Ser-10 and acetylated at Lys-14, ChIP (chromatin immunoprecipitation) 
experiments showed that the phophoacetyl-H3 isoform was associated with the c-jun and c-
fos promoters in an EGF stimulation dependent manner. In addition, the H3 N-terminal 
peptide phosphorylated at SerlO is a better substrate for the histone acetyltransferase GCN5 
than the unphosphorylated peptide, suggesting the synergistic coupling of phosphorylation 
and acetylation during transcription (Cheung et al., 2000b). 
However, phosphorylation of SerlO was also correlated with mitotic chromosome 
condensation (Wei et al., 1998). An S10A mutation of the H3 gene in Tetrahymena caused 
segregation defects during mitosis, demonstrating the importance of SerlO phosphorylation 
for appropriate mitotic chromosome behavior (Wei et al., 1999). Recent studies identified 
Ipll/aurora kinase as the mitotic histone H3 SerlO kinase and Glc7/PPl as the phosphatase 
catalyzing the reverse reaction to maintain the balance of SerlO phosphorylation (Hsu et al., 
2000). Analysis of the D. melanogaster Aurora B kinase by a RNAi approach in Schneider 2 
(S2) cells demonstrated that mitotic SerlO phosphorylation is controlled by the Aurora B 
kinase as well (Giet and Glover, 2001). 
How could SerlO phosphorylation have multiple personalities, i.e., how could the 
same modification be involved in both gene transcription and mitotic condensation? One 
hypothesis is that H3 phosphorylation actually opens up chromatin to enable the access of 
condensation machinery during mitosis, and transcription machinery during gene expression 
(Cheung et al., 2000a), therefore the pathway in action is determined by the protein factors 
that bind to the modified histones. Another attractive theory is the combined "histone code" 
hypothesis (Strahl and Allis, 2000). For example, the combination of SerlO phosphorylation 
and acetylation at adjacent lysine residues (K9 or K14) might serve as a signal for 
transcription, while phosphorylation at SerlO and Ser28 together might dictate condensation 
(Goto et al., 1999). Both of these proposed models need to be tested in future studies. 
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Nevertheless, the extensive study of H3 SerlO phosphorylation has supported the 
fundamental role of this modification in the regulation of chromatin structure and function. 
Intrigued by this basic concept, we investigated the possible role of JIL-l in the SerlO 
phosphorylation pathway. Our data support that JIL-l regulates SerlO phosphorylation at 
interphase in Drosophila (Wang et al., 2001). 
As mentioned above, in addition to acetylation and phosphorylation, histone tails can 
also be modified by methylation, ubiquitination, and ADP-ribosylation. A recent study 
reported the SET domain containing proteins, human Suv39Hl and mouse Suv39hl, possess 
histone methyltransferase (HMT) activity and preferentially methylate lys9 of histone H3 
(Rea et al., 2000). Suv39Hl and Suv39hl are homologs of D. melanogaster Sur(var)3-9 and 
S. pombe clr4. The catalytic region of these proteins was mapped to the SET domain and 
adjacent cysteine rich regions. To better understand the relationship of phosphorylation, 
acetylation, and methylation, in-vitro peptide kinase assays with Ipll/aurora were carried out 
(Rea et al., 2000). These experiments showed that Lys9-acetylated peptide and Lys 14-
acetylated peptide can serve as better substrates than unmodified peptide for the Ipll/aurora 
kinase, while Lys9 dimethylated peptide was poorly phosphorylated. Conversely, the SerlO 
phosphorylated peptide cannot be methylated by Suv39hl. These data suggest that Lys9 
methylation and SerlO phosphorylation are antagonistically regulated, while acetylation and 
phosphorylation are synergistically regulated. In vivo, Suv39hl null cells exhibit a defect in 
chromosome condensation and segregation, which was also observed in the Su(var)3-9 
mutant in D. melanogaster and the clr4 mutant in S. pombe, suggesting that the HMT 
function is important for mitotic chromosome behavior. In addition, SerlO phosphorylation 
level in Suv39hl null fibroblast cells is elevated, supporting the hypothesis that Lys9 
methylation impairs SerlO phosphorylation in vivo (Rea et al., 2000). Another study found 
that HP1 (heterochromatin protein 1), an important protein involved in the maintenance of 
heterochromatin structure and PEV regulation, specifically binds to H3 methylated at Lys9 
(Lachner et al., 2001). The domain that recognizes methylated K9 was mapped to the 
chromodomain of HP1. In vivo, heterochromatin HP1 binding is lost in the Suv39hl mutant 
fibroblast cells. The notion that Suv39hl functions as an HMT (histone methytransferase) 
and creates binding sites for HP1 in heterochromatic regions was confirmed by the study of 
clr4 and swi6, the homologs of Suv39hl and HP1 respectively, in 5. pombe (Nakayama et al., 
2001). 
With the importance of histone modification in chromatin structure and function 
being more and more appreciated, we can expect the coming of more thorough studies of 
how histone modifications are involved in development, signal transduction, and human 
disease. 
The role of chromatin modifying activities in signal transduction pathways 
As discussed above, the involvement of RSK-2 and MSK1 in H3 SerlO 
phosporylation plays an important role in c-fos and c-jun gene expression. The fact that these 
two enzymes can be activated by the MAP kinase pathway suggests a pathway whereby an 
extracellular stimulus, such as EGF, activates the MAP kinase pathway, leading to the 
activation of RSK-2 and MSK1, which in turn leads to histone modification and the 
elicitation of a specific cellular response (Deak, et al., 1998; Pierrat et al., 1998). 
Another piece of evidence linking histone modification to signal transduction comes 
from the study of how Retinoblastoma (Rb) protein inhibits E2F mediated gene expression. 
The Rb protein regulates cell cycle progression by binding the E2F transcriptional activator. 
This silences specific genes that require E2F as an activator and are required for entering the 
S phase of the cell cycle. Until recently, the mechanism of how Rb silences E2F dependent 
genes was poorly understood. The finding that HDAC1 (histone deacetylase 1) and Rb 
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interact with each other provided a breakthrough in the field (Brehm et al., 1998; Luo et al., 
1998; Magnaghi-Jaulin et al., 1998). As the Rb protein is recruited to the promoters of E2F 
dependent genes by interacting with the transcriptional activation domain of E2F, it brings 
HDAC1 with it, resulting in deacetylation of histones and producing a chromatin 
environment unfavorable for gene expression. Furthermore, if histone deacetylation is 
inhibited by the histone deacetylase inhibitor TSA (trichostatin A), Rb mediated transcription 
repression is abolished. These studies support a model whereby histone deacetylase works 
together with the Rb protein to control cell cycle progression. 
Other studies have disclosed how chromatin modifying complexes, such as the ATP-
dependent chromatin remodeling complexes and the histone acetyltransferase complexes, are 
orchestrated to work together with other general transcription machinery during gene 
expression. The induction of IFN-B gene expression by viral infection is a good example. The 
IFN-B enhanceosome, containing multiple transcription factors, is first recruited to the 
promoter to the IFN-B promoter after viral infection. Histone acetylase GCN5 complex is 
then recruited to acetylate histone proteins. After histone acetylation, the CBP-PolII 
holoenzyme complex is bound, followed by the binding of the SWI/SNF chromatin 
remodeling complex. Finally, the joining of TFIID to the promoter leads to transcription 
(Agalioti et al., 2000). 
Another good example of coordinated action of chromatin modifying activities and 
general transcription machinery is the developmental and cell cycle specific control of HO 
endonuclease gene expression in yeast (Cosma et al., 1999). The HO endonuclease mediates 
the a to a (or a to a) mating type switch. The expression of HO is restricted to the "mother 
cell" at the late G 1 phase of the cell cycle. Therefore, the mating type can only be switched 
in the mother cell. The recruitment of transcription factors, SWI/SNF chromatin remodeling 
complex, and SAGA histone acetyltransferase complex, takes place in an orderly way. The 
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transcription factor SWI5p is bound to the promoter first, followed by the SWI/SNF 
chromatin remodeling complex. Later, the SAGA acetylation complex is recruited to the 
promoter. At last, these factors are joined by the transcription factor SBF and PolII to 
activate transcription of the HO gene. 
Dosage compensation in Drosophila melanogaster 
In many species, females have two X chromosomes and males have only one X. The 
difference in X chromosome number is sometimes important for sex determination during 
early development. However, many of the X-chromosome encoded proteins are equally 
required in both sexes, therefore, an equity of X chromosome gene expression must be 
achieved (Kelley and Kuroda, 1995; Kelley and Kuroda, 2000; Lucchesi, 1996). To reach 
this equity, distinct mechanisms are used in different species (Fig 5A). In mammals, one of 
the two X chromosomes in females is painted by the Xist RNA, highly condensed to form 
heterochromatin-like architecture in interphase, and transcriptionally inactive (Kelley and 
Kuroda, 1995). The random selection of either the maternal or the paternal X chromosome 
for silencing during early development is controlled by the subtle balance of Xist and Tsix 
expression from opposite directions at the same locus (Lee et al., 1997). 
In C. elegans, the two X chromosomes in the cells of hermaphrodites are specifically 
bound by the dpy (or dumpy) gene products and the expression of each of the two X 
chromosomes is reduced to half of that of the male X chromosome. One of these DPY 
proteins, DPY-27, shares high homology with the SMC (structural maintenance of 
chromosomes) family of proteins that are components of the condensation complex in 
Xenopus, suggesting that higher order chromatin structure might be modified to allow 
transcription to occur at a reduced level (Chuang et al., 1994; Hirano, 1995; Hirano et al., 
1995). 
Fig 5. Mechanisms of dosage compensation. (A) Different mechanisms have evolved to 
reach dosage compensation. In mammals, transcription from one of the female X 
chromosome is mostly shut down by condensing the chromosome to form a heterochromatin-
Iike structure during interphase. In C. elegans, the expression of both hermaphrodite X 
chromosomes is reduced to roughly half of that of the male single X chromosome to achieve 
an equality. In D. melanogaster, equity is reached by doubling the gene expression from the 
single male X chromosome. (B) The formation and assembly of the MSL complex is 
restricted to the male cells. In female cells, the S XL protein blocks the translation of msl-2 
mRNA, therefore, a stable MSL complex is not formed. In males, there is no translation 
inhibitor, S XL, thus the MSL2 protein is produced. Our current model is that the MSL-2 
protein is assembled with MSL-1, -3, MOF, MLE, JIL-l and two non-encoding RNAs, roxl 
and roxl, to form a 2MD complex that is specifically associated with the male X 
chromosome to regulate histone modifications, such as H4 lys 16 acetylation, H3 SerlO 
phosphorylation and lys 14 acetylation, and chromosome structure in order to reach dosage 
compensation. 
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En D. melanogaster, the male X chromosome is decondensed due to the function of a 
group of genes, collectively called the msl (male specific lethal) genes. Expression of genes 
on the male X chromosome is doubled to reach an equivalent level with that of the two 
female X chromosomes. Genetic studies have identified five genes that are required for the 
viability of males. The proteins encoded by these genes, Male specific lethal-1, -2, -3, 
Maleless, and Male-absent on the first (MOF), form a 2MD protein complex, termed the 
MSL dosage compensation complex, which binds to hundred of bands on the male polytene 
X chromosomes in salivary gland nuclei. There are an extensive number of publications 
concerning the molecular characterization and functional studies of each of these proteins 
(Maleless or MLE (Gorman et al., 1993; Kuroda et al., 1991; Lee et al., 1997); MSL-1 
(Palmer et al., 1993; Scott et al., 2000); MSL-2 (Copps et al., 1998; Kelley et al., 1995); 
MSL-3 (Gorman et al., 1995); MOF (Akhtar and Becker, 2000; Hilfiker et al., 1997; Smith et 
al., 2000)). By studying genes highly expressed in the nervous system, two non-encoding 
RNA genes, roxl and rox2, were identified whose RNAs are specifically associated with the 
male X chromosome and are components of the dosage compensation complex (Franke and 
Baker, 1999; Meller et al., 1997; Amerin and Axel, 1997). The roxl and roxl genes 
themselves are located on the X chromosome and are two of the approximate 35 entry sites 
for the binding of the MSL complex. Interestingly, the roxl gene inserted to autosomal sites 
can still nucleate and induce extensive spreading of the MSL complex on the autosomes in a 
certain range from the insertion site. This raised a plausible model to explain how the MSL 
complex binds to the male X chromosome. After transcription, the rox RNAs are only able to 
diffuse locally and form some nucleation sites for the MSL dosage compensation complex on 
the male X. Therefore, the MSL complex is spread a certain distance from the roxl and roxl 
transcription sites (Kelley et al., 1999). Are there more rat-like RNAs? Only time will tell. 
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There is quite a collection of functional protein domains represented in the MSL 
complex. The MLE protein has high similarity with RNA helicase and possesses RNA 
binding motifs. MSL1 has an acidic region at its N-terminus, which is a characteristic of 
transcription activation domains. The MSL3 protein has two chromodomains that are often 
found in protein factors responsible for transcriptional repression. MSL2 has a zinc-binding 
ring finger domain that is also found in proteins that maintain repressive chromatin structure. 
MOF encodes a chromodomain containing histone acetyltransferase of the MYST family, 
which is likely to be the acetylase responsible for the acetylation of H4 at the Lys 16 site 
(Bone et al., 1994; Smith et al., 2000). The finding that the DNA binding domain of Gal4 
fused with MOF could activate the expression of a reporter gene with GAL4 binding sites in 
its promoter in yeast directly placed MOF in a pathway that leads to transcription (Akhtar 
and Becker, 2000). The ability of MOF to activate transcription in this test is dependent on its 
active HAT domain, suggesting H4 Lys 16 acetylation is a signature for gene expression and 
is probably a positive code for dosage compensation as well. However, the two-fold increase 
of gene expression on the male X must be regulated precisely. Therefore, the finding of both 
repression and activation domains in the dosage compensation complex should not be a 
surprise (Lucchesi, 1996). 
How can MSL complex function be restricted to the males? The translational 
regulation of MSL2 by Sex lethal (SXL) might be the key (Kelley et al., 1997). SXL is a 
female specific RNA binding protein that regulates alternative RNA splicing in the sex 
determination cascade. In the case of MSL-2, however, the binding of SXL to the msl-2 RNA 
inhibits translation instead of causing alternative splicing. Because of the presence of SXL in 
females, the MSL2 protein is not made and the dosage compensation complex fails to form 
and to bind to the X chromosome. Conversely, because there is no SXL in males, the MSL2 
protein is produced and the MSL complex is formed on the male X chromosome (Fig 5B). 
28 
The study of JIL-l in our lab suggests that JIL-l is involved in the dosage 
compensation process. The JEL-1 protein level is elevated on the male X chromosome, while 
it remains evenly distributed on the X chromosome and autosomes in females (Jin et al., 
1999). That the distribution of JIL-l on the male X overlaps with that of the MSL proteins 
and JIL-l could be coimmunoprecipitated with MSL proteins suggest JIL-l can associate 
with the MSL complex (Jin et al., 2000; Kelley and Kuroda, 2000). That the JIL-l 
immunocomplex can phosphorylate the SerlO site in a synthetic H3 N-terminal peptide in 
vitro (unpublished data from Y. Wang) and the level of SerlO phosphorylation is decreased 
in JIL-l mutants suggest that JIL-l is involved in the H3 SerlO phosphorylation pathway. 
Furthermore, the levels of both H3 SerlO phosphorylation and H3 double modification 
(SerlO phosphorylation and Lys 14 acetylation) are elevated on the male X chromosome, 
which was detected by antibody staining. In addition, the pattern of modified H3 isoform 
staining colocalizes with that of the JIL-l staining. Our data suggest SerlO phosphorylation 
and Lys 14 acetylation on H3 could coexist with the H4 Lys 16 acetylation as the histone code 
for dosage compensation (Wang et al., 2001). 
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CHAPTER 3. MATERIALS AND METHODS 
Fly stocks 
All of the fly stocks were maintained according to standard methods in Roberts, 1986. 
The mutant phenotypes not discussed here can be found in Lindsley and Zimm, 1992 and on 
fly base (http://www.flybase.org). Oregon R flies were used as wild type in the studies 
described in this dissertation. The EP(3)3657/TM6B Tb stock was provided by Dr. Todd 
Laverty at the Berkeley Drosophila Genome Project. The w; A2-3 Sb/TM2 Ubx stock, used 
as a transposase source for imprecise P-element excision, was a generous gift of Dr. Linda 
Ambrosio. The GFP-JIL-1 transgenic lines were previously described in Jin et al., 1999. Flies 
were maintained at room temperature, however, to improve polytene chromosome squashes, 
larvae were grown at 18°C. 
Antibodies 
The antibodies used include: 
JIL-l antibodies: 
ODIN (a rabbit polyclonal antibody made by our laboratory) 
Hope (an affinity purified rabbit polyclonal antibody made by our laboratory) 
1008/1007 (purified chicken polyclonal IgY antibody) 
V5 mAb (a mouse monoclonal antibody against a V5 epitope from Invitrogen Inc.) 
MSL antibodies: (generous gifts from Dr. Kuroda and Dr. Kelley) 
MSL1 antibody (affinity purified rabbit polyclonal antibody against MSL1) 
MSL2 antibody (affinity purified rabbit polyclonal antibody against MSL2) 
MSL3 antibody (affinity purified goat polyclonal antibody against MSL3) 
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Modified histone antibodies: 
H4Acl6 antibody (affinity purified rabbit polyclonal antibody against the H4 isoform 
acetylated at K16 available from Serotec Inc.) 
pH3S10 antibody (affinity purified rabbit polyclonal antibody against the H3 isoform 
phosphorylated at S10 sites available from Upstate Biotechnology Inc. or Cell 
Signaling Technology Inc.) 
pH3S10Acl4 antibody (affinity purified rabbit polyclonal antibody against the 
double modified H3 by phosphorylation at S10 and acetylation at K14 
available from Upstate Biotechnology Inc.) 
Other antibodies: 
Lamin DmO antibody R836 (rabbit polyclonal antibody against DmO, a generous gift 
of Dr. Fisher) 
Lamin DmO mAb T40 (a mAb against DmO, a generous gift of Dr. Paddy and Dr. 
Saumweber) 
Tubulin mAb (a mAb against a-tubulin available from Sigma) 
7F1 mAb (a mAb made in our laboratory using GST-Jl (the C-terminal region of 
SW59) as antigen) 
G39 mAb (a mAb against leech Gliarin made by our laboratory (Xu et al., 1999)) 
Histone H3 antibody (a goat polyclonal antibody against the C-terminal sequence of 
histone H3 available from Santa Cruz Biotech.) 
PCR and primers 
Primers were designed using the Oligo 5 program and synthesized by the DNA 
Sequencing and Synthesis Facility at Iowa State University. Primers used were listed in 
Appendix A. The PCR reaction was done following the instruction in Sambrook and Russel, 
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2000. A typical 50ul PCR reaction included 5ul of lOxPCR buffer, 8ul of 1.25mM dNTPs, 
3ul of each primer (5pmoI/uI), 2.5 units of Taq DNA polymerase, appropriate amount of 
DNA template, and H20). In order to sequence the products, PCR amplified fragments were 
sometimes cloned into the pGem-T vector (Promega Inc.). 
Peptides 
Two peptides, H3N25 (ARTKQTARKSTGGKAPRKQLATKAA) and H3N25S 10A 
(ARTKQTARKATGGKAPRKQLATKAA) were synthesized by the Protein Facility at Iowa 
State University. H3N25 is the H3 N-terminal 25 residues, while H3N25S10A has an S 10 to 
A10 substitution. These two peptides were used in in vitro immunocomplex kinase assays. 
Molecular cloning 
Many molecular methods not described in this chapter can be found in Sambrook and 
Russel (2000) or in a Protocols and Applications Guide from Promega Inc. Plasmid 
preparation was done using the Wizard minipreps kit (Promega). DNA fragment gel recovery 
was done following the GeneClean kit protocol (Midwest Scientific Inc). 
GST fusion protein expression in E. coli and purification 
cDNA fragments or PCR products of interest were cloned in frame into the pGEX4T 
vectors (Amersham Pharmacia Biotech). The cloned fragment was sequenced to confirm the 
correct reading frame and sequence. To express GST fusion proteins, E. coli strain BL21 was 
often used to produce more full length fusion proteins. Cells with the cloned insert were 
grown to ODgoo of about 1.0, then the inducer IPTG was added to a concentration of O.lmM. 
After induction of 4-6 hours, cells were harvested and sonicated in PBS supplemented with 
protease inhibitors (aprotinin, 1.5ug/ml, PMSF, ImM). Cell Iysate was clarified by 
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centrifugation at 13,000 rpm for 12 min at 4°C. Total protein solution was incubated with 
glutathione agarose beads for 4-6 hours with continuous mixing at 4°C. Bound protein was 
washed with 20 times bead volume of ice cold PBS supplemented with protease inhibitors. 
Protein retained on the beads can be used as affinity matrix for pull down experiment or can 
be eluted with glutathione solution to purify fusion protein. Many GST fusion protein 
constructs made were described in the results and discussion (Chapter 4). A list of constructs 
can be found in Appendix B. 
Antibody generation 
The purified GST fusion protein, GST-J1, was injected into BALB/c mice at 21 day 
intervals to generate mAbs. After the third boost, mouse spleen cells were fused with Sp2 
myeloma cells and monospecific hybridoma lines were established and used to produce 
antibody using standard procedures (Harlow and Lane, 1988). This work was carried out by 
the Hybridoma Facility at Iowa State University. 
S2 cell culture and gene expression in S2 cells 
The Drosophilci Schneider 2 (S2) cell line was grown in the Shields and Sang M3 
insect medium (Sigma) supplemented with L-glutamine and antibiotics. S2 cell transfection 
was carried out using a calcium and phosphate method described in the instruction manual 
(Drosophila Expression System, Invitrogen). The establishment of stably tansfected cell lines 
and protein expression were done following the instruction manual. Total S2 cell lysate was 
prepared in IP buffer (20mM Tris.HCl, lOmM EDTA, l.OmM EGTA, 150mM NaCl, 0.2% 
Triton X-100, 0.2% NP-40, 2mM Na3V04, ImM PMSF, and l.5ug/ml aprotinin, pH 8.0). 
Cell lysate was prepared from healthy and rapidly growing S2 cells. S2 cells were collected 
by spinning for 3-5min at 3000rpm, resuspended in IP buffer to a final concentration of 1-
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2xl07 cells/ml. Cells were broken to dissolve proteins by sonication 2-3 times, 30 seconds 
each, with 1 min interval. The insoluble cell debris was removed by spinning for 15min at 
12,000rpm at 4°C. Cell lysate could be stored at -80°C for months. 
In vitro immunocomplex kinase assays 
Buffers used for in vitro immunocomplex kinase assays include IP buffer (20mM 
Tris.HCl, lOmM EDTA, L.OmM EGTA, L50mM NaCl, 0.2% Triton X-100, 0.2% NP-40, 
2mM Na3V04, ImM PMSF, and 1.5ug/ml aprotinin, pH 8.0) and kinase assay buffer (20mM 
Hepes, pH7.4, lOmM MgCl,, 2mM Na3V04, ImM DTT). S2 cell lysate was prepared as 
described above. Total histone proteins or purified histone H3 was purchased from 
Boehringer-Mannheim. The H3N25 and H3N25S10A peptides were described above. If the 
cell lysate has been stored at -80°C for some time, some proteins may become insoluble. 
Lyaste was centrifuged to remove any insoluble materials before using. Three tubes with 1 ml 
IP buffer and 5ul of 50% protein-G beads slurry into each were prepared. The protein-G 
beads were quickly washed three times with 1ml IP buffer to remove ethanol in which the 
beads were preserved. 300ul IP buffer was added to each tube and lOul ODIN anti-serum or 
lOul preimmune rabbit serum were added to two tubes separately to pre-bind the antibody to 
the beads. The third tube was used as a control for mock IP. In order to pre-clear the S2 cell 
lysate, lOOul of 50% protein-G beads slurry was washed three times with IP buffer and 
combined with 600ul of S2 lysate, which should contain about 6xl06 cells. Pre-clearing and 
pre-binding were continued for about 4 hours at 4°C with continuous mixing. The pre-bound 
antibodies on protein-G beads were washed three times quickly with 1ml of IP buffer to 
remove unbound antibody. The pre-cleared lysate was transferred to a new tube after 
spinning and brought up to a total volume of 900ul with IP buffer. 300ul of the precleared S2 
lysate, which had about 2xl06 cells, was combined with ODIN protein-G beads, preimmune 
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protein-G beads, or protein-G beads only. The immunoprecipitation was continued for 
another 4 hours with continuous mixing. After IP, the immunocomplex was washed 5 times 
with lml IP buffer for 10min each, and three times with I ml kinase assay buffer for 10 min 
each. After extensive washing, the immunocomplex was divided into two tubes. In some 
experiments, one aliquot was used for western blots and the other was used for kinase 
reactions. In the peptide kinase assays, one aliquot was used for H3N25 peptide and the other 
was used for H3N25S10A peptide. Kinase assays were performed as follows. The kinase 
assay buffer was removed after washing. 24ul of kinase buffer was added to each tube, 
together with a substrate, 3ul (12ug) of H3N25 peptide, 3ul H3N25S10A (12ug) peptide, or 
5ul (25ug) of histone H3, and 3ul y-32P-ATP (lOuCi/ul). The reactions were carried out for 
30min with mixing at room temperature. After the reactions were finished, the reaction 
mixture was applied to P81 paper, dried briefly, and then washed three times with a large 
amount of 0.6% phosphoric acid for 5 min each and 1 time with acetone for 3 min. Paper 
squares were put into 5ml of scintillation buffer and the amount of incorporated 32P was 
determined by scintillation counting. If histone H3 was used as a substrate, proteins in the 
reaction were separated on SDS-PAGE. The gel was stained, dried, and exposed to X-ray 
film to detect phosphorylation signal. 
Co-immunoprecipitation (co-IP) 
For co-IP, an appropriate amount of antibody of interest was coupled to 5ul of protein 
G sepharose beads (Sigma, capacity, 1.5ug IgG/ul of beads) for 4 hours at 4°C on a rotating 
wheel in 250ul of IP buffer (20mM Tris.HCl, lOmM EDTA, LOmM EGTA, 150mM NaCl, 
0.2% Triton X-100, 0.2% NP-40, 2mM Na3V04, ImM PMSF, and 1.5ug/ml aprotinin, pH 
8.0). If the amount of antibody used was over the binding capacity of the protein G beads, 
excess antibody was washed away with IP buffer. S2 cell lysate (about 2-3xl06 cells in 200ul 
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IP buffer for each IP) prepared in IP buffer was pre-cleared by incubating with 5ul normal 
sera of appropriate species and 20ul protein G beads for 2 hours at 4°C. Precleared cell lysate 
and protein-G beads pre-loaded with antibodies were combined and incubated overnight at 
4°C with continuous mixing. After immunoprecipitation, the protein G beads were washed 3 
times 10 min with 1ml of IP buffer. The immunocomplex was analyzed by SDS-PAGE and 
western blot. Signals on western blots were detected with ECL reagents (Amersham-
Pharmacia). 
In-vitro GST pull down assays 
For in-vitro protein-protein interaction assays, about 0.5-lug of GST or a GST-fusion 
protein of interest expressed in E. coli were coupled with glutathione agarose beads. The 
GST protein was often used as a negative control. S2 cell lysate was pre-cleared by 
incubating with glutathione agarose beads for 4 hours at 4°C with continuous mixing. The 
coupled beads were incubated with 300ul of pre-cleared S2 cell lysate (containing about 
lxlO6 cells) at 4°C for 6 hours on a rotating wheel. Then the beads were washed 4 times of 
10 min with 1ml of IP buffer and proteins retained on the beads were analyzed with SDS-
PAGE and western blots. Signals on western blots were detected with ECL reagents 
(Amersham-Pharmacia). 
Immunostaining 
Polytene chromosome staining was performed following the protocol from Dr. 
Kuroda with slight modifications as follows. The most photogenic polytene chromosomes 
were produced with larvae grown in uncrowded vials at 18°C, which were periodically given 
modest supplements of yeast and water. The best chromosomes were obtained from the first 
wave of larvae to climb up the side of the vial. The salivary glands were dissected under a 
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dissecting microscope in PBS. The dissected salivary glands were fixed in formaldehyde and 
50% acid as follows. First, 4 ml of 5x formaldehyde (0.74g paraformaldehyde in 4 ml of H,0 
with 28ul of IN KOH) was made by warming the solution at 65°C to dissolve 
paraformaldehyde. Dissected salivary glands were first fixed in Fix L solution (IxPBS, 1% 
Triton X-100, 1 xformaldehyde in H20) for about 45 seconds, then fixed in Fix 2 solution 
(50% glacial acetic acid, 1 xformaldehyde in H20) for about 2 min. After the above fixation, 
salivary glands were transferred to lactoacetic solution (16% lactic acid, 50% acetic acid in 
H20). About 15ul of lactoacetic solution was transferred together with the fixed salivary 
gland to a silconized cover slip. The cover slip with the salivary gland was picked up using a 
clean (or a polylysine treated) slide. The polytene chromosomes were gently spread by gently 
tapping with the eraser end of a pencil and carefully squashed between several layers of lens 
paper. The slides were frozen in liquid nitrogen, allowed to warm up for 3-5 seconds, and the 
coverslip was removed with a clean razor blade, and immediately placed into ethanol to 
dehydrate for 1 hour at room temperature. The slides were rehydrated in PBT (PBS with 
0.2% Triton X-100), 2 times 30 min. After this, the slides were blocked in blocking solution 
(usually 5% NOS (normal goat serum) in PBT) for 2-3 hours at 4°C. Primary antibodies were 
appropriately diluted according to their titer in blocking solution and incubated with the 
slides overnight at 4°C. After washing for 3 times 10 min, the slides were stained with 
appropriate secondary fluorescence coupled antibodies diluted in the blocking solution for 2 
hours at room temperature in dark. The slides were washed, stained with Hoechst (0.2ug/ml 
in PBS) for several minutes and washed in PBS for several minutes, then mounted and 
observed under a fluorescent microscope. Fluorescence signal was collected using the Scion 
image program and imported to the Adobe Photoshop program in which the image was 
processed and pseudocolored. 
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Embryo staining was performed essentially as previously described f Walker et al, 
2000). Embryos (0-5 hour) were dechorionated in a 50% Chlorox solution for about 2 min, 
washed with 0.7M NaCl/0.2% Triton X-100, and fixed in a 1:1 heptane/fixative mixture for 
20 min with vigorous shaking at room temperature. The fixative wa_s either 4% 
paraformaldehyde in PBS or Bouin's fluid (0.66% picric acid, 9.5% formalin., 4.7% acetic 
acid). Vitelline membranes were removed by shaking embryos in heptane/methanol at room 
temperature for 30 seconds. Rehydration and antibody staining was done as described above 
for polytene chromosome staining. 
Whole mount salivary gland nuclei staining was performed by fixing thie nuclei with 
paraformaldehyde in PBS. Briefly, salivary glands were dissected in PBS. About 5 pairs of 
salivary glands were placed in the center of a slide along with 50ul of PBS. The salivary 
glands were gently compressed under a cover slip by sliding the cover slip back and forth 
several times. The cover slip was then removed and 50ul of the Fix 1 solution <lx PBS, 1% 
Triton X-100, Ix formaldehyde in H20) was added and covered by a piece of parafilm. The 
tissue was fixed at 4°C for 20 min and brought to room temperature for 5 min, then washed 
in PBT (PBS with 0.2% of Triton X-100) 3 times, 10 min each. The slides were blocked, 
stained, and observed as described above for polytene chromosomes. 
Western blot analysis 
Western blots were carried out essentially as described in Harlow and Lane, 1988. 
Briefly, protein samples of S2 cell lysate or total larvae extract were prepared in IP buffer. 
Proteins were separated on SDS-PAGE gels, transferred to nitrocellulose, incuT)ated with a 
specific antibody using appropriate dilution overnight at 4°C. The secondary a_ntibody was 
either an HRP-labeled anti-rabbit IgG or an HRP-labeled anti-mouse IgG (Bi-o-Rad). The 
signals were detected with the ECL kit (Amersham Pharmacia). 
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Fly viability assays and rescue experiments 
To assay the embryo hatching rate, embryos produced by wild type (Oregon R) or 
homozygous EP(3)3657 parents were collected on apple juice agar plates. The hatching rate 
was scored and recorded 24 and 48 hours after egg collection under a dissection microscope. 
The hatching rate was calculated as the percentage of the embryos hatched out to become 
larvae. The pupae or larvae of homozygous mutants can be distinguished from their 
heterozygous siblings by not carrying the tubby marker. The larvae or pupae carrying a tubby 
marker are short and fat, while those without the tubby marker are slim and long. Thus, the 
non-tubby pupae, which are the JIL-1 homozygous mutants, were collected into separate 
vials to observe eclosion rate. The number of flies hatched from pupae was recorded every 
day until no more flies emerged. The eclosion rate was calculated as the percentage of 
number of hatched flies out of the number of total pupae collected. To perform rescue 
experiments, a GFP-JIL-1 (GF29.1, carrying a P[hs83-GFP-JIL-1, w+) transgene on the 
second chromosome was used to cross with JDL-1 mutants (Jin et al., 1999). The hatch rate of 
embryos and eclosion rate of pupae of JIL-1 mutants carrying this GFP-JIL-1 transgene were 
observed. To compare the hatch rates and eclosion rates of the wild type, mutants, and 
rescued mutants statistically, a %2test was used. 
Yeast two hybrid 
Yeast two-hybrid analysis is a powerful tool to study protein-protein interaction. In 
yeast two-hybrid screening, a protein (or a part of a protein) of interest was fused with the 
Gal4-BD (DNA binding domain) and transformed into yeast strains with inducible reporter 
genes containing the Gal4 binding sites. If another protein fused with the Gal4-AD 
(activation domain) can interact with the protein of interest and was co-transformed into the 
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yeast cells, the GaI4-AD was brought to the promoter of reporter genes via protein-protein 
interaction. This would lead to the expression of reporter genes. 
In order to search for proteins that can interact with JIL-1, four JIL-1 two hybrid 
constructs were made, including BD-NTD (N-terminal domain), BD-fCDI (kinase domain I), 
BD-KDII (kinase domain ID, and BD-CTD (C-terminal domain). The BD-CTD was used to 
screen a Drosophila 0-2 hour early embryonic yeast two-hybrid library (a generous gift from 
Dr. Ambrosio) following the protocol from Stratagene. The BD-FCDI was used to screen a 
Drosophila 0-18 hour yeast two-hybrid library following the protocol from Clontech. The 
candidate interacting proteins identified from two-hybrid screens were further tested using 
other protein-protein interaction methods. 
Bioinformatics 
Ho mo log sequence searching was performed using the BLAST program (Altschul et 
al., 1990) at NCBI (National Center for Biotechnology Information at 
http://www.ncbi.nlm.nih.gov). The GeneSeqer program (Usuka et al., 2000) was used to 
search for EST sequences from a certain genomic region (http://deepc2.zool.iastate.edu/cgi-
bin/gs.cgO. The homologous sequence alignments using the Clustalw program (Thompson et 
al., 1994) were performed at http://www2.ebi.ac.uk/clustalw. The analysis of the genomic 
sequence of lola for zinc finger containing regions was performed in the Microsoft word'98 
program using the "find" function to search consensus sequences, CXXC, HXXXXC, and 
HXXXXH ('X' can be any amino acid). Fly genome information can be accessed from the 
flybase website (http://www.flybase.org). 
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CHAPTER 4. RESULTS AND DISCUSSION 
The JIL-1 immnunocomplex can phosphorylate histone H3 in vitro 
The JIL-1 kinase belongs to the MSK subfamily of AGC kinase family which 
includes the cyclic nucleotide-dependent kinases (PKA and PKG), and diacetylglycerol 
dependent protein kinase C (PKÇ). This family of kinase preferentially phosphorylates 
Ser/Thr sites surrounded by basic residues (Morrison, et al., 2000). Because JIL-1 is 
associated with chromosomes (Fig 2 and 3 in Chapter 1, and Jin et al., 1999), it likely has 
access to histones whose tails have many Ser/Thr surrounded by basic residues. Therefore, 
histone proteins were tested as possible substrates for the JIL-1 immunocomplex 
immunoprecipitated from Schneider 2 cell lys ate. In in vitro kinase assays, histone H3 was 
phosphorylated by the JIL-1 immunocomplex but not by the immunocomplex of PIRS (gre-
immune rabbit serum), suggesting that histone H3 was a putative substrate of the JIL-1 
pathway (Fig 6B). In addition, a protein with a molecular weight close to the size of JIL-1 in 
the JIL-1 immunocomplex was phosphorylated in in vitro kinase assays, suggesting JIL-1 
may possess autophosphorylation activity (Fig 6A). These data led to a proposal of histone 
H3 as a substrate candidate for the JIL-1 immunocomplex and possibly of the J IL-1 kinase 
itself (Jin et al., 1999). 
Studies of MSKl and Rsk-2, two close ho mo logs of JIL-l, showed that these two 
kinases could phosphorylate histone H3 (Thomson et al., 1999; Sassone-Corsi et al., 1999). 
Moreover, MSKl can phosphorylate the SerlO site of H3 in in vitro immunocomplex kinase 
assays (Thomson et al., 1999). Recent evidence indicated that Rsk-2 was required for EGF 
stimulated H3 SerlO phosphorylation in vivo (Trivier et al., 1996; Sassone-Corsi et al., 1999). 
In fibroblast cells from Rsk-2 mutant mice, H3 SerlO phosphorylation was not induced after 
EGF stimulation, but was restored by the introduction of a Rsk-2 transgene. These data 
Fig 6. Kinase assays with JIL-1 immunocomplex. (A) JIL-1 putatively has 
autophosphorylation activity. The JIL-1 complex was immunoprecipitated by a JIL-1 
polyclonal antibody, ODIN. After kinase reactions, part of the product was applied for a 
western blot to detect the JIL-1 protein; part of the product was separated by SDS-PAGE, 
stained with Coomassie Blue, dried and exposed to X-ray film to detect the phosphorylation 
signal. There was a phosphorylated band on the X-ray film of the size corresponding to that 
of JIL-1 detected on western blot. The arrow indicates the heavy chain of rabbit IgG that was 
detected on western blot. (B) The JIL-1 immunocomplex phosphorylated H3 strongly (right 
lane) but the immunocomplex of PIRS did not (left lane), which was shown in the upper 
panel where the phosphorylated substrates were separated by SDS-PAGE and detected with 
an X-ray film. The lower panel indicated that similar amount of H3 protein was used in both 
reactions as shown by Coomassie Blue staining of the same SDS-PAGE gel exposed the X-
ray film. (C) The JIL-1 immunocomplex phosphorylated the SerlO site of a synthetic peptide, 
H3N25. The peptide sequences of H3N25 and H3N25S10A were shown with an arrow 
indicating the S10A substitution. The H3N25 peptide was efficiently phosphorylated by the 
JIL-1 immunocomplex, showing a signal of incorporated 32P of about 40000±11100 (lane I), 
while the signal of incorporated 32P on H3N25S10A peptide was decreased more than six 
fold to only 6300±800 (lane 3). In the negative control group, where the immunocomplex of 
the PRIS was tested with the H3N25 peptide as substrate, the amount of J2P signal detected 
was 4400±2100 (lane 2) (modified from Jin et al., 1999). 
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placed Rsk-2 downstream in the EGF-MAP kinase pathway that regulates histone H3 
phosphorylation in response to extracellular mitogen. Since JIL-1 has high homology to 
MSKl and Rsk-2, it was of interest to study whether JIL-1 might also be involved in the H3 
SerlO phosphorylation pathway. To address this question, we designed two pepetides: 
H3N25 contains the N-terminal 25 amino acids of H3 sequence, while H3N25S10A has the 
same sequence as H3N25 except for the SerlO residue was replaced by an alanine (Fig 6C). 
In in vitro immunocomplex peptide kinase assays, the JIL-1 immunocomplex demonstrated 
strong kinase activity toward the wild type peptide, H3N25, (Fig 6C, Lane 1) but very low 
kinase activity toward the mutant peptide, H3N25S10A (Fig 6C, Lane 3), showing about 6 
times decrease. As a negative control, the immunocomplex of PIRS (pre-immune rabbit 
serum) was tested with wild type peptide as substrate (Fig 6C, Lane 2). The phosphorylation 
signals in lanes 2 and 3 are roughly comparable. These data suggest that the JIL-1 
immunocomplex can preferentially phosphorylate the SerlO site in a synthetic peptide. 
One limitation of immunocomplex kinase assays is the possibility that other kinases 
may be co-immunoprecipitated with the kinase of interest, making it hard to ascribe the 
phosphorylation activity detected to the kinase immunoprecipitated by the antibody. An 
alternative approach that could avoid this problem is to express the kinase to high level in an 
expression system and purify the kinase by biochemical methods. Future efforts to express 
and purify an active JIL-1 kinase would have many benefits for the JIL-1 study. 
JIL-1 interacts with the MSL dosage compensation complex 
The higher level of JIL-1 protein on the male X chromosome (Fig 3, D and E) and the 
colocalization of JIL-1 and the MSL proteins (Fig 4) suggest JIL-1 could play a role in 
dosage compensation. Is there any direct protein-protein interaction between JIL-1 and 
proteins in the MSL dosage compensation complex in addition to their colocalization? To 
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address this question, two approaches, co-immunoprecipitation (co-IP) and the GST-fusion 
protein pull down (PD) assays, were used to examine possible interactions between JIL-1 and 
the MSL proteins. 
The MSL proteins can form a stable 2MD protein complex as shown by gel-filtration 
chromatography and co-IP studies (Copps et ai., 1998). Therefore, if JIL-1 interacts with any 
of the MSL proteins, it is very likely other proteins in the MSL complex could also be 
recovered in in-vitro protein interaction studies, such as co-IP and GST-PD assays. Using the 
V5 antibody against a JEL-1-V5 fusion protein expressed in the S2 (Schneider 2) cells to 
immunoprecipitate JIL-1, both MSL-1 and MSL-2 were coimmunoprecipitated with JIL-1 
(Fig 7B). Conversely, anti-MSL-l, -2, and —3 antibodies were able to co-IP JIL-1-V5 fusion 
protein as well (Fig 7A). In control experiments, the nonspecific antibody could not co-IP the 
JIL-1-V5 fusion protein, suggesting the co-IP results are specific to the antibodies used. To 
carry out in vitro GST-PD protein-protein interaction assays, five separate GST fusion 
proteins were prepared, GST-JIL-1, GST-NTD (N-terminal domain), GST-KDI (kinase 
domain I), GST-KDII (kinase domain IT), and GST-CTD (C-terminal domain) (Fig 7C). The 
GST-JIL-1, GST-KDI, and GST-KDII fusion proteins bound to glutathione agarose beads 
could pull down MSL proteins, but not the GST, GST-CTD, or GST-NTD (Fig 7D). These 
data suggested that there is physical interaction between JIL-1 and the MSL complex. 
Furthermore, the fact that two domains of the JIL-1 protein can interact with the MSL 
complex suggests JIL-1 may interact with more than one protein of the MSL complex or 
more than one domain of the same protein. The involvement of multiple protein interaction 
sites in the same protein was found as a common theme for protein interaction in huge 
protein complexes, For example, different parts of the MSL1 protein interact with different 
proteins of the MSL complex (Scott et al., 2000). Currently, we do not know which 
protein(s) of the MSL complex directly interacts with JIL-1. Further study of JTL-l and MSL 
Fig 7. Interaction of JIL-1 and the MSL protein(s) of the dosage compensation complex. (A) 
The antibodies, anti-MSL-1, -2 and —3, can co-IP JIL-1-V5 fusion protein expressed in S2 
cells (lane 3). For the control in lane 2, either normal rabbit serum was used for anti-MSL-1, 
-2 antibodies or normal goat serum was used for anti-MS L3 to match with the species where 
the specific antibodies were produced. The controls showed that JEL-1-V5 was specifically 
coimmunoprecipitated by anti-MSL antibodies but not the negative control serum. S2 cell 
lysate loaded in lane 1 was used to indicate the size of the JIL-1-V5 protein. (B) The V5 
mAb that immunoprecipitates the JIL-1-V5 fusion protein can also co-IP MSL proteins, as 
detected by the anti-MSL-1, and —2 antibodies on western blots. The MSL proteins were not 
detected in the negative control lane 2, where the mAb V5 was used to immunoprecipitate 
from S2 cells that were not transfected with the JIL-1-V5 expression vector. S2 cell lysate 
was loaded in lane 1 to indicate the size of the proteins. (C) A schematic drawing of the GST 
fusion proteins made in E.coli for the GST-pull down study. The amino acid residues 
included in the fusion proteins are numbered at the end of each construct. (D) GST-JIL-1 
(lane 3), GST-KDI (lane 5), GST-KDII (lane 6) can pull down MSL proteins, but not the 
GST alone (lane 2), GST-NTD (lane 4), or GST-CTD (lane 7). Lane I is the S2 cell lysate to 
indicate the size of the MSL1 or MSL3 protein (modified from Jin et al., 2000). 
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interaction with purified proteins or using the two-hybrid system in yeast may yield a better 
understanding of how JIL-1 interacts with the MSL complex. 
Identification and generation of a series of JIL-1 mutant alleles 
As the genome sequence of the JIL-1 locus was available from the NCBI (National 
Center for Biotechnology Information) DNA database, the cDNA sequence of JIL-1 was 
compared with the genomic sequence using the BLAST program (Adams et al., 2000). The 
JIL-1 gene contains eight exons separated by seven introns, which are scattered in a_bout 
15kb region of the genome (Fig 8 A). The regions encoding the protein, including the regions 
that encode KDI (kinase domain I) and KDII (kinase domain II), are indicated below 
whereby the starting methionine is located in the second exon. By searching the DNA 
database at NCBI using the cDNA sequence of JIL-1, a flanking sequence of an EP element 
insertion site was found, which indicates an EP element was inserted at the end of ex_on I 
about 700bp upstream of the starting methionine (Fig 8B). An EP element carrying a Gal4 
regulated promoter was used to produce fly lines that drive protein overexpression in a 
controllable and tissue specific manner to look for phenotypes caused by protein 
overexpression (R.0rth et al., 1998). In this JIL-l EP element insertion line (referred to as JEP3 
or EP(3)3657), although the EP element blocked the normal transcription of JIL-1 mRJNA, 
the JIL-1 protein was expressed at about 11.4+1.6% (n=4) of that of the wild type (Fig SC). 
To generate additional mutant alleles of JIL-1, especially a JIL-I null, Dr. Kristen M. 
Johansen and Weiguo Zhang carried out imprecise P-element excision experiment to screen 
for P-element excision events that took away a part of the JIL-1 genomic DNA. Weiguo 
mapped the part of genomic DNA removed by the imprecise P-element excision events using 
PCR (Fig 8B). Two JIL-1 alleles identified in this screen, Z60 and Z2, which have only about 
3.0±0.8% (n=4) and 0% of JIL-1 protein expression, respectively, were selected for further 
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Fig 8. Identification and generation a series of JIL-1 mutant alleles. (A) A diagram of the 
JIL-1 genomic map. JIL-1 has eight exons separated by seven introns that are located in a 
15kb region. The position of exons is indicated by black boxes and the cutting sites of several 
major enzymes are indicated at the top. The regions of the gene that encode the JIL-1 protein, 
including KDI and KDII, are indicated at the bottom. (B) The original EP element 
represented by a triangle in the EP3 allele was inserted about 700bp upstream of the starting 
methionine in exon II. Two more JIL-1 mutant alleles, Z60 and Z2, were generated from the 
original EP3 by imprecise P-element excision. The regions carried away by the EP element 
are indicated by dashed lines. (C) The JIL-1 protein expression level is reduced to about 10% 
in EP3, 3% in Z60, and 0% in Z2 in this western blot detected with affinity purified anti-JIL-
1 Hope antibody. The amount of tubulin loaded in each lane is roughly equal as detected with 
anti-tubulin mAb. (D) JIL-1 protein expression is reduced to an undetectable level in Z2 
(lane 2). The amount of JIL-1 in Z2 was restored by a GFP-JIL-1 transgene on the second 
chromosome (lane 3) to a comparable level with the wild type JIL-1 as detected on western 
blots with the Hope antibody (modified from Wang et al., 2001). 
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analysis (Fig 8C). In the Z60 allele, the 5' end of the EP element, the upstream regulatory 
region, and most of the exon I of JIL-1 were removed as depicted by dashed line in fig 8B. In 
the Z2 allele, the 3' end of the EP element, intron I, exon II, and most of intron II, including 
the starting methionine, were removed (Fig 8B). The next methionine in the JIL-1 cDNA 
sequence is in the middle of KDI, therefore, the Z2 allele should be a JIL-1 null, which was 
confirmed by western blots analysis (Fig 8C). To carry out rescue experiments in the J IL-1 
mutants to confirm the mutant phenotypes were caused by JIL-1, we used a GFP-JIL-1 
transgene on the second chromosome, which is a slightly slower moving band on western 
blots than that of JIL-1 due to the added GFP moiety (Fig 8D). The GFP-JIL-1 was expressed 
at a comparable level to that of endogenous JIL-1, making it suitable for the rescue 
experiments. These three alleles, EP3, Z60, and Z2, comprise a series of JIL-1 mutants from 
hypomorph, strong hypomorph, to null and are very useful to study the JIL-l function in 
vivo. 
JIL-1 is essential for the viability of both males and females; the male viability is more 
sensitive to the level of JIL-1 protein 
By studying the JIL-1 mutant phenotypes, we found the viability of both males and 
females is greatly reduced as the level of JIL-1 protein is decreased (Table 1). The eclosion 
rate of homozygous EP(3) pupae produced by heterozygous parents was 81%, which was 
dropped to 69% for homozygous EP(3) pupae produced by homozygous parents. This 
reduction of eclosion rate in EP(3) pupae produced by homozygous parents may be caused 
by a lower level of maternal JIL-1 product, as the heterozygous parents have a normal copy 
of JIL-1 to encode maternal product, while homozygous parents do not. In the first 
generation of homozygous Z60, in which the JIL-1 protein level was reduced to 3%, the 
eclosion rate was only 0.5%. The eclosion rate further dropped to 0% in homozygous Z2 
50 
Table 1. The viability and male/female ratio 
are affected in JIL-1 mutants 
Genotype Eclosion rate (%)a % of observed M/Fb 
EP(3)/TM6 Tb ND 107 (331/308) 
EP(3)/EP(3) c 81 73 (206/354) 
EP(3)/EP(3) d 69 48 (467/968) 
Z60/Z60 0.5 32 (22/59) 
Z2/Z2 0 -
GFP-JIL-1 ;EP(3) NDe 97 (484/500) 
a eclosion rate (%) = number of flies eclosed/number of pupae collected x 100 
b % of observed M/F = number of males observed/ number of females observed x 100 
c EP3 flies were produced by heterozygous parents 
d EP3 flies were produced by homozygous parents 
e ND = not determined 
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pupae when there was no JIL-1 protein detectable. These data demonstrated that JIL-1 is 
important for the viability of both males and females. This is also consistent with the global 
distribution of JIL-1 protein on the X chromosome and autosomes in both sexes, suggesting 
JIL-1 plays a general function in addition to its putative function in dosage compensation. 
Since JIL-1 protein is elevated on the male X chromosome and JIL-1 can interact 
with the MSL complex, we intentionally counted and compared the number of surviving 
males and females of the homozygous JIL-1 mutants to see whether the reduced levels of 
JIL-1 can affect the viability of males and females differently. Interestingly, the number of 
males was less than that of females, suggesting males are more sensitive to the reduction of 
JIL-1 protein (Table 1). For example, the number of males in the first generation of 
homozygous EP3 was 73% of that of females and was dropped to 48% in the second 
generation of homozygous EP3. We reasoned that the decrease of male to female ratio could 
be caused by the lower level of JIL-1 maternal product in the second generation of EP(3) as 
well. In the small number of surviving homozygous Z60, in which the JIL-1 protein level is 
about 3% of wild type, males were only 32% percent of females. In addition, the male to 
female ratio was recovered to 97%, close to that of the wild type, when the GFP-JIL-1 was 
introduced into the EP(3) mutant. These data support that JIL-1 plays a role in dosage 
compensation, which is in agreement with its elevated level on the male X chromosome and 
its interaction with the MSL proteins. The importance of JIL-1 for the viability of both males 
and females also explains why JIL-1 was not identified in the genetic screens looking for a 
male specific lethal phenotype. 
JIL-1 is required for early embryonic development 
Although the eclosion rate of homozygous EP3 pupae produced by homozygous 
parents is 69%, the hatching rate of embryos of homozygous parents is only 4% (16/400), 
showing a dramatic decrease from the observed 83% (333/402) hatching rate of wild type, 
Oregon R, flies with statistical difference (PcO.OOl). To investigate the cause of this reduced 
hatching rate, the embryos produced by homozygous EP3 parents were stained with Hoechst 
to label DNA in chromosomes and with tubulin antibody to visualize tubulin in mitotic 
apparatus. We found a series of mutant embryonic phenotypes from abnormal to roughly as 
normal as that of the wild type embryos, which reflects the 4% hatching rate of these 
embryos, indicating the variability of embryonic phenotypes could be due to the roughly 10% 
of JIL-1 protein expression left in these animals. Chromosomes in the abnormal mutant 
embryos were disintegrated (Fig 9B), fragmented (9C), and sometimes in big clumps (9E). In 
contrast, chromosomes in wild type embryos at this stage should be nicely arranged and 
evenly distributed (Fig 9A). By double labeling of embryos with Hoechst and tubulin, we 
found, in some embryos, there were many centrosomes separated from the big clumps of 
chromosome and dispersed in the embryos (fig 9D, E, and F). In some other embryos, the 
microtubule spindles with aberrant morphology were formed and associated by the 
disintegrated and fragmented chromosomes (fig 9G, H, and I). These observations suggest 
JIL-1 may play a role in early embryonic development and is involved in the maintaining of 
the integrity of chromosomes in the early embryos. However, how the low level of JtL-1 
could induce these mitotic defects is still a question for future study. One possible 
explanation is the mitotic defects are caused by the disorganization of the higher order 
chromatin structure during interphase (see next section), which activated certain cell cycle 
checkpoint(s) to block the mitotic progress and eventually led to the disintegrating of 
chromosomes in mutant embryos. Nevertheless, other possibilities, such as JIL-1 plays a 
direct role in mitosis, may exist as well. 
Interestingly, some forms of abnormal chromosome morphology observed, in EP3 
mutant embryos are very similar to that found in the mutant of pitkinD, a dominant gain-of-
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Fig 9. JIL-1 is required for early embryonic development. (A) A wild type embryo at the 
early developmental stage was stained with Hoechst to show the chromosome 
morphology and evenly distributed nuclei that have migrated to the surface of the 
embryo. (B and C) Mutant EP3 embryos were stained with Hoechst. Chromosomes in 
these embryos were either disintegrating (B) and/or severely fragmented (C). (D, E, and 
F) Double labeling of embryo with Hoechst and anti-tubulin antibody showed that DNA 
was in some big clumps and small fragments (E) and centrosomes stained by tubulin 
antibody were uncoupled from DNA and. dispersed in the embryos. (G, H, and I) Double 
labeling of embryo with tubulin antibody and Hoechst, abnormal microtubule spindles 
pointed out by arrows (G) were formed on the aberrant chromosomes (modified from 
Wang et al., 2001). 
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function mutation that enhances position-effect variegation and regulates chromatin function 
(Kuhfittig et al., 2001). This suggests multiple protein factors may be involved in 
maintaining chromatin structure in early embryos. Moreover, a recent study showed that JIL-
1  i s  hap lo id  in su f f i c i en t  t o  ma in ta in  t he  no rma l  t r ansmis s ion  o f  a  Drosoph i la  
minichromosome, suggesting JIL-1 regulates the faithful segregation of the chromosomes 
during cell division (Dobie et al., 2001). 
JIL-1 is required for maintaining higher order polytene chromosome structure 
The distribution of JIL-1 protein on polytene chromosomes encouraged us to examine 
the polytene chromosomes in the JIL-1 mutants. Using Hoechst to label DNA and MSL2 
antibody to stain MSL2 on the male X chromosome, we found that the polytene chromosome 
structure in JIL-1 mutants was severely distorted, suggesting JIL-1 is required for the 
maintenance of higher order chromatin structure in salivary gland nuclei (Fig 10). The wild 
type polytene chromosomes have long and extended arms with defined bands stained by 
Hoechst and MSL-2 antibody (Fig 10 A, B, and C). However, the length of the polytene 
chromosome was decreased, and the banding pattern of Hoechst and MSL2 disappeared to 
degrees correlating with the reduced levels of JIL-1 protein in the mutants. The architecture 
of polytene chromosomes from homozygous EP3 was slightly changed (Fig 10E) and more 
severely altered in the Z60 and Z2 mutants (Fig 10H, K and N). In homozygous EP3 males, 
both the Hoechst pattern and MSL2 staining pattern were subtly changed with a lower 
number of discernible bands on the slightly shortened X chromosome (Fig 10 D, E, and F). 
In homozygous Z60 and Z2 males, the X chromosome morphology was strongly perturbed 
with total disappearance of banding pattern of Hoechst and MSL2 (Fig 10 G, H, I, J, K, and 
L). In homozygous Z60 mutant, the chromosome structures varied from strongly abnormal to 
Fig 10. JIL-1 is required for maintaining higher order polytene chromosome structure. (B, E, 
H, K, and N) Hoechst staining of polytene chromosomes from wild type, EP3, Z60, Z2 
males, and a Z2 female, respectively. (C, F, I, L, and O) MSL2 antibody staining of polytene 
chromosomes with their genotype labeled. (A, D, G, J and H) The composite figures of 
Hoechst and MSL2 antibody staining with the genotype labeled (modified from Wang et al., 
2001). 
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less abnormal, which is probably due to the residual amount (about 3%) of JIL-1 left. 
However, in the Z2 null mutant, the higher order structure of polytene chromosomes was 
affected to 
roughly the same degree as the example shown in fig 10K. Noteworthy is that the male X 
chromosome structure was especially affected in the JIL-1 mutants but the female X 
chromosome is affected to the same degree as autosomes (compare 10K and ION). The male 
X in homozygous Z2 totally lost the bands stained by Hoechst and MSL2, suggesting the 
unique male X chromosome is more sensitive to the reduced level of JIL-1. Whether this is 
the reason that male viability is more sensitive to the JIL-1 function, however, is still 
unknown. Furthermore, that the association of MSL2 with the male X did not disappear in 
the JIL-1 null Z2 suggests JIL-1 is not required for the binding of MSL-2 to the male X. 
The above results support that JIL-1 function is required for maintaining normal 
higher order polytene chromosome structure. This notion is further confirmed by the rescue 
experiments with a GFP-JIL-1 transgene on the second chromosome. The GFP-JIL-1 
introduced to the Z2 mutant was localized to polytene chromosomes with a pattern similar to 
that of JIL-1, with an elevated level on male X chromosomes and a lower level on autosomes 
in males, which was detected by anti-JIL-1 antibody staining (Fig 1 ID). Chromosome 
structure was restored to the level of wild type with long and extended arms, and defined 
Hoechst and MSL2 staining patterns (Fig 11C and D). The structural difference between the 
rescued chromosome and the mutant chromosome could be easily perceived (Fig 11A 
compared with Fig 11C). 
As discussed in the literature review, the regulation of chromatin structure could have 
a profound effect on the function of chromatin, such as gene expression. Therefore, the 
perturbed chromosome structure described above may have a profound effect on the 
chromatin function. Based on the chromosomal territory theory, the surface area of chromatin 
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Hoechst/MSL2 antibody JIL-1 antibody 
Fig 11. The perturbed polytene chromatin structure was rescued by a GFP-JIL-1 transgene. 
(A) The polytene chromosome structure in the Z2 mutant was strongly perturbed. The X-
chromosome was labeled by MSL2 antibody. (B) There is no JIL-1 antibody staining on 
polytene chromosomes in the Z2 mutant. (C) The chromosome structure was restored by the 
GFP-JIL-1 transgene in the Z2 mutant, so was the MSL2 staining pattern. (D) GFP-JIL-1 was 
localized similarly as native JIL-1 on polytene chromosomes, which was upregulated on the 
male X and distributed with lower level on autosomes. (JIL-1, white; MSL2, red; Hoechst, 
green) (modified from Wang et al., 2001). 
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is important for efficient transcription. Therefore, the shortened polytene chromosomes with 
reduced surface areas would be unfavorable for transcription if the above theory were 
correct. Furthermore, the modification of histones has been shown to regulate chromatin 
structure and functions in various ways (Cheung et al., 2000). Could the phenotype observed 
in JIL-1 be correlated with histone modification given the fact that the JIL-1 
immunocomplex can phosphorylate histone H3 in vitro (see next two sections)? 
The H3 SerlO phosphorylation and H3 SerlO phosphory!ation-Lysl4 acetylation levels 
are increased on the male X chromosome 
That the JIL-1 immunocomplex could phosphorylate the H3 SerlO residue in vitro 
and the reports that RSK-2 and MSKl, two of the JIL-1 homologs in higher eukaryotes, 
could phosphorylate the SerlO site of H3 in vivo encouraged us to study whether JIL-1 is 
involved in the SerlO phosphorylation in vivo as well (Sassone-Corsi et al., 1999; Thomson 
et al., 1999; Cheung et al., 2000; Clayton et al., 2000). To answer this question, we applied a 
commercially available antibody that recognizes the H3 isoform phosphorylated at the SerlO 
residue. The staining of polytene chromosomes with this antibody by following a traditional 
acid squash protocol yielded inconsistent results that varied from different lots of antibody. 
We reasoned that the acid treatment might have destroyed the epitopes or interfered with 
antibody performance. Therefore, we developed an alternative method to stain the polytene 
nuclei by compressing the salivary gland gently under a cover slip and fixing with 
paraformaldehyde/PBS. The staining signal of pH3S10 (phospho-SerlO of H3) with this 
method is consistent and repeatable with antibodies from two independent sources, making it 
suitable for our study. 
Double labeling of salivary gland polytene nuclei with both JIL-1 antibody and the 
pH3Serl0 antibody showed that the pH3Serl0 signal was enriched on the male X 
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chromosome stained by the JIL-1 antibody (Fig 12C; Jin et al., 1999). In addition, the signal 
of pH3Serl0 staining overlaps with that of JIL-1 staining as shown by the predominant 
yellow signals in the composite fig 12A. It has long been known that H4Acl6 colocalizes 
with the MOF protein on the male X chromosome. Did nature do the parallel trick to have the 
pH3S10 colocalize with a kinase, JIL-1? Nonetheless, the colocalization data further linked 
JIL-1 function to the H3 SerlO phosphorylation pathway. 
Recent studies have demonstrated that SerlO phosphorylation and Lys 14 acetylation 
are synergistically regulated processes (Clayton et al., 2000; Cheung et al., 2000b; Rea et al., 
2000). The phosphorylated H3 N-terminus can be more efficiently acetylated by the GCN5 
family of histone acety(transferases (HATs), and vice versa. To analyze whether these two 
kinds of H3 modifications were synergistically regulated on the male X as well, we applied a 
pH3S10Acl4 antibody that recognizes the double modified H3 with phosphorylated SerlO 
and acetylated Lys 14 (pH3S10Acl4). It was found that the double modified H3 isoform was 
also enriched on the male X chromosomes stained by JIL-1 antibody (Fig 12E, F) and was 
colocalized with the JIL-1 staining as indicated by the overwhelming yellow signal in the 
composite fig 12D. This finding leads to a plausible model that phosphoacetyl-H3 might 
configure a chromatin structure together with acetylated H4 at Lys 16 to regulate dosage 
compensation (Fig 5). However, this model is simplified to fit with most of the reported data 
so far and needs to be further tested and modified in the future. Nevertheless, the combining 
of multiple histone modifications on the male X again emphasized the importance of 
covalent histone modifications in the various processes templated by DNA/chromatin. 
The phosphorylation of H3 SerlO is involved in two separate pathways. The interphase 
phosphorylation is correlated with gene expression (Sassone-Corsi et al., 1999; Cheung et al., 
2000) and the mitotic phosphorylation is correlated with chromosome condensation and 
segregation (Wei et al., 1998). Correspondingly, there are two enzymatic systems that 
Fig 12. The H3 SerlO phosphorylation (pH3S10) and H3 SerlO phosphorylation-Lys 14 
acetylation (pH3S10Acl4) levels are increased on the male X chromosome. (A, B, and C) A 
salivary gland polytene nucleus was stained with both JIL-1 antibody and anti-pH3S10 
antibody. The pH3S 10 signal was elevated on a chromosome (C) that was also labeled by the 
JIL-1 antibody (B). The labeling of JIL-1 antibody and that of the pH3S10 antibody largely 
overlap with each other as shown by predominant yellow color in the composite figure (A). 
(D, E, and F) A polytene nucleus was double labeled with both JIL-1 antibody and 
pH3S!0Acl4 antibody, which recognizes the H3 isoform phosphorylated at SerlO and 
acetylated at K14. The pH3S10Acl4 labeling (F) was elevated on a chromosome stained by 
JIL-1 antibody (E) and was predominantly colocalized with the staining of JIL-1 as shown by 
the predominant yellow color in the composite figure CD). (G, H, and I) Neuroblast squash 
of the Z2 mutant was stained with pH3S10 antibody and Hoechst. The pSIO signal was 
present on the condensed mitotic chromosomes but noa in surrounding interphase nuclei (I) 
(modified from Wang et al., 2001). 
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control H3 SerlO phosphorylation during interphase and mitosis. The MSK1 and RSK-2 
kinases were found as the interphase SerlO kinases (Sassone-Corsi et al., 1999; Thomson et 
al., 1999), while the Ipl 1/aurora kinase was found as the mitotic SerlO kinase (Hsu et al., 
2000). Therefore, it is likely there are two enzymatic systems existing in D. melanogaster to 
control SerlO phosphorylation at different stages of the cell cycle. To investigate whether 
mitotic SerlO phosphorylation was affected in the JIL-1 mutant Z2, neuroblast squashes were 
stained with pH3S 10 antibody. The phospho-SerlO signal (Fig 121) was present on the 
condensed mitotic chromosomes but not on the surrounding interphase nuclei (Fig 12H, data 
from W. Zhang). This result together with a recent report of the fly Aurora B kinase as the 
mitotic SerlO kinase strongly argues that JIL-1 is not involved in the H3 SerlO 
phosphorylation at mitosis but could be involved in the interphase H3 SerlO phosphorylation 
signaling pathway. 
The H3 SerlO phosphorylation level in JIL-1 mutant larvae is greatly reduced 
The converging data of in vitro kinase assays and in vivo colocalization studies of 
pH3S 10 and JIL-1 support that JIL-1 might be involved in the SerlO phosphorylation signal 
transduction pathway. This notion was further supported by western blot analysis using the 
pH3S10 antibody. To evaluate whether or to what extent, the SerlO phosphorylation signal 
was reduced when the JIL-1 protein level was reduced or absent, western blots were carried 
out with total third instar larva extract of wild type, EP3, Z60, and Z2 animals. Samples were 
separated by SDS-PAGE and detected with pH3S 10 antibody. Comparing with that of wild 
type, the phosphorylation level of H3 SerlO was reduced to 40.0±17.4% (N=4), 19.4+14.4% 
(N=4), and 4.6+1.9% (N=4) in EP3, Z60, and Z2 respectively, albeit the amount of H3 
protein in each extract was roughly equal. One example of such a western blot was shown in 
fig 13A. The degrees of reduction of pH3S10 were correlated with the decreased levels of 
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Fig 13. Histone H3 SerlO phosphorylation level in JIL-1 mutant larvae was greatly reduced. 
(A) Total larvae extract from WT (wild type), EP3, Z60 and Z2 animals were separated by 
SDS-PAGE for western blots and probed with pH3S10 antibody. The pH3S10 signal was 
reduced to roughly 40%, 20%, and 5% in EP3, Z60 and Z2 respectively. Tubulin, lamin 
DmO, and H3 antibodies were used to demonstrate that roughly equal amount of protein 
sample was loaded in each lane. (B) The reduced level of pH3S10 in homozygous Z2 (the 
middle lane) could be restored by a GFP-JIL-1 transgene in the Z2 mutant (the last lane). 
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JIL-1 protein in these animals. These data suggest the normal level of H3 S10 
phosphorylation in third instar larvae is dependent on the JIL-1 signal transduction pathway. 
To further confirm this idea, rescue experiments were employed with a GFP-JIL-1 
transgene on the second chromosome. We found the reduced level of H3 SerlO 
phosphorylation can be restored by the GFP-JIL-1 transgene, which was shown on western 
blots detected with the pH3S10 antibody (Fig 13B, data from W. Zhang). 
Taken together, these data support a hypothesis that JIL-1 is involved in a signal 
transduction pathway regulating SerlO phosphorylation in vivo. Because the H3SerlO 
phosphorylation level in Z2 was reduced to some 5% of that of wild type in the third instar 
larvae, and most of the cells at this developmental stage are in interphase, we propose that the 
JIL-1 pathway is the predominant signal transduction pathway regulating H3 SerlO 
phosphorylation in interphase. 
Applying the anti-pH3S lOAc 14 antibody to study the level of double modified H3 in 
JIL-1 mutants, we found the amount of double modified H3 was also reduced in the JIL-1 
mutant Z2 and could be restored by a GFP-JIL-1 transgene on the second chromosome (data 
not shown). 
Lamin DmO, a candidate interacting with the C-terminal domain of JIL-1 
Nuclear lamin forms a fibrous network underneath the surface of the nuclear 
membrane, called nuclear lamina, which has long been thought as a structural component to 
support and maintain the shape of the nuclear envelope. However, more recent studies 
suggested that lamin and lamin associated proteins play a broad range of functions in the 
nuclei, such as participating in DNA replication and transcriptional regulation(Moir et al., 
2000). 
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Nuclear lamin belongs to the family of intermediate filament proteins with an a-
helical rod domain that can be divided into four segments, coil la, coil lb, coil 2a and coil 2b 
(Johansen and Johansen, 1995). Lamin proteins can polymerize to form intermediate 
filaments by head-to-tail binding with each other (Hutchison et al., 2001; Stuurman et al., 
1996). The nuclear lamina structure and nuclear envelope is subject to rapid disassembly at 
the beginning of mitosis and reassembled at the end of mitosis (Newport and Spann, 1987). 
The assembly/disassembly of lamina is at least partially controlled by the 
dephosphorylation/phosphorylation of nuclear lamin. Phosphorylated lamin protein 
demonstrates different solubility and polymerization behavior from unphosphorylated lamin 
protein (Lin and Fisher, 1990). The phosphorylation of lamin is governed by kinases, such as 
protein kinase A, C, and p34cdc2, which lead to disassembly of the lamin filament. 
Conversely, the dephosphorylation of lamin is controlled by phosphatase PP1 (protein 
phosphatase I), which leads to the reformation of the intermediate filament (Stuurman, 1997; 
Thompson et al., 1997). 
At the beginning of M phase, the nuclear envelope is broken down to small nuclear 
envelope vesicles, which are reassembled to form the nuclear envelope at the end of mitosis. 
The assembly of the nuclear envelope is mediated by the binding of nuclear membrane 
vesicles to chromosomes. The fusion of these vesicles on the surface of chromosomes leads 
to the formation of the nuclear envelope, which encompasses all of the chromosomes (Pfaller 
et al., 1991; Ulitzur et al., 1997). Evidence showed that the attachment of nuclear membrane 
vesicles to chromosomes was mediated by the interaction between lamin and the N-terminal 
tails of histone H2A and H2B (Goldberg et al., 1999). 
In mammals, there are three types of lamins, designated as lamin A, B, and C. The A 
and C type lamins are produced from the same gene by alternative splicing, share 
considerable homology with each other, and have relatively neutral isoelectric points 
(Gruenbaum et al., 1988). B type lamin, however, is quite acidic and was found to be 
associated with the DNA replication sites (Moir et al., 1994). In D. melcinogcister, there is 
one major type of lamin, lamin DmO, which is expressed widely and closely related to the B-
type lamin in mammals. Flies also have an A (or C)-type lamin whose expression is limited 
to some cells at certain developmental stages ( Riemer et al., 1995; Cohen et al., 2001). There 
are two RNA isoforms of lamin DmO produced by alternative splicing, which encode the 
same protein. The newly synthesized DmO protein is rapidly processed by post-translational 
modification to generate two proteins with molecular weight of 74KD and 76KD, 
respectively (Gruenbaum et al., 1988). 
Recent studies of nuclear lamin associated proteins, such as lamin B receptor (LBR), 
lamin associated proteins (LAP1 and LAP2) and emerin, revealed that these proteins can 
interact with lamins and in many cases attach chromatin as well. Thus, these proteins offer a 
connection between the nuclear envelope and chromatin (Wilson et al., 2001). The 
interaction between LBR and HP I (heterochromatin protein _!), a protein repressive for 
transcription, suggests nuclear lamin and/or its associated proteins might be involved in 
transcriptional regulation as well (Ye et al., 1997). However, the picture of how nuclear 
lamina and associated proteins regulate the nuclear function, such as transcription, DNA 
replication, and how lamins are involved in the internal nuclear structure organization is far 
from clear. The study for more lamin interaction proteins will provide more insight into the 
nuclear organization and function. 
To better understand the function of JIL-1, a chromsomes/chromatin associated 
Ser/Thr kinase, we carried out yeast two-hybrid screens to search for proteins that can 
interact with JIL-1. By screening a 0-2 hour Drosophila early embryo yeast two-hybrid 
library (a generous gift from Dr. Linda Ambrosio), the CTD (C-terminal domain) of JIL-1 
was found to interact with the fly lamin DmO protein. Of the seven positive clones identified 
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and sequenced from this yeast two-hybrid screen, two of them, C13g and C8d, were found to 
be two independent clones containing lamin DmO fragments of different length (Fig 14A). 
The C8d clone contains the coding sequence for residues 219-622 of DmO, including the 
coil2a and coil2b regions and the C-terminal domain of DmO, while the C13g clone contains 
the cDNA sequence encoding residues 270-622 of DmO. 
When the GaI4-BD-CTD (Gal4 DNA binding domain fused with the CTD) of JIL-1 
and the AD-C8d (AD, Gal4 transcription activation domain) or the AD-C13g constructs were 
co-transformed into yeast, the lacZ reporter gene expression was turned on. This was shown 
in paper-lift color assays to measure the activity of LacZ (Fig 14B). As control, when the 
Gal4-BD-NTD (N-terminal domain) of JIL-1 construct was co-transformed with either of 
these two AD domain containing lamin DmO clones into yeast, the LacZ reporter gene was 
not expressed. These data suggest that there is specific interaction between the lamin DmO 
and the CTD of JIL-1 in yeast cells. To further investigate the interaction between JIL-l-
CTD and lamin DmO, we carried out GST-PD (pull down) assays with GST-CTD fusion 
protein expressed in E. coli. The GST-CTD fusion protein coupled on glutathione agarose 
could pull down lamin DmO, which was detected on western blots with lamin DmO antibody 
(Fig 14C). In the control experiments, GST protein alone was unable to pull down DmO. The 
interaction of JIL-1 and DmO was further studied by co-IP (immunogrecipitation) 
experiments. The lamin polyclonal antibody R836 (a generous gift from Dr. Paul Fisher) was 
able to co-IP JIL-1-V5 fusion protein expressed in the fly S2 cells, which was detected by the 
V5 mAb on western blot (Fig 14D). In control, normal rabbit serum could not co-IP JIL-1-
V5 (Fig 14D). 
The yeast two-hybrid and in vitro protein interaction assay data support the JIL-1 
CTD may interact with lamin DmO. However, it is not known whether this protein-protein 
interaction observed in the in vitro systems or in yeast cells is physiologically relevant. It has 
Fig 14. Protein-protein interaction studies of JIL-1 and lamin DmO. (A) A schematic drawing 
of the lamin DmO protein structure. The protein has 622 amino acids and contains a rod 
domain with four coil regions, coil la, lb, 2a, and 2b. The corresponding lamin DmO 
fragments included in clone C8d and C13g were depicted below the diagram of the DmO 
protein. (B) The expression of LacZ reporter gene in yeast cells was induced by the 
interaction between the JIL-1 CTD (C-terminal domain) and lamin DmO. From left to right, 
the positive control showed interaction between TRAF2 (TNFR associated factor 2) and 
CD40 (a kind of tumor necrosis factor receptor, Ni et al., 2000) shown by blue color 
produced by lacZ activity in the yeast cells in the paper lift assay. The interaction between 
C8d and CTD of JIL-1 turned on the LacZ expression (blue color). There was no LacZ 
expression in the yeast with C8d and NTD of JIL-1 (red color). There was interaction 
between the C13g and CTD of JIL-1 (blue). No interaction was found between NTD of JIL-1 
and C13g (red). (C) The GST-CTD fusion protein coupled with glutathione agarose beads 
pulled down lamin DmO, but the GST alone did not. S2 lysate was loaded on western blots to 
indicate the size of lamin proteins. (D) The anti-lamin R836 serum can co-IP JIL-1-V5 
expressed in the S2 cells (right lane) but not the control normal rabbit serum (middle lane). 
S2 lysate was loaded in the left lane to indicate the size of JIL-1-V5. 
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long been thought that lamin protein is only distributed underneath the nuclear envelope but 
not in the nuclear interior. One reason that the interior lamin DmO was not observed for such 
a long time is the limitation of conventional fluorescent microscopy, which cannot 
distinguish the on focus signal and out-of-focus signal well. Therefore, the low level of 
internal signal inside the nucleus was considered as out-of-focus signal coming from the 
surrounding lamina staining. With the help of confocal microscope, the interior lamin DmO 
distribution in the salivary gland nuclei was reported. Moreover, the interaction of DmO and 
topoisomerase II was shown by co-IP assays (Fisher et al, 2001). 
Nonetheless, the putative interaction between lamin DmO and JIL-1 is quite 
intriguing. Does this interaction exist in cells? Since JIL-1 is associated with chromatin, is 
this putative interaction involved in the regulation of chromatin structure? These questions 
might be very interesting to be explored in the future study of JIL-1. Considering the 
complexity of the nuclear structure, the interaction between nuclear proteins must be 
important to coordinate many nuclear events. The nucleus is organized into functional 
domains for transcription, RNA processing and DNA replication. The individual 
chromosomes occupy a certain territory that is seperated by inter-chromosomal channels 
(Lamond and Eamshaw, 1998). Heterochromatin is often found around the nuclear envelope. 
Noteworthy is that the telomere regions of polytene chromosomes are associated with the 
nuclear envelope (Dr. Gary Karpen, personal communication), which are regions that the 
JIL-1 staining was also found (Fig 4). These observations suggest the internal nuclear 
structure and chromatin are deliberately organized and regulated. The finding of the interior 
localization of lamins and the discovery of the interaction between LBR (lamin B receptor) 
and chromatin associated HP1 suggest there is a cross-talk between the nuclear envelope and 
chromatin (Ye et al., 1997). The view of the nuclear envelope has been changed from a static 
structure to a more dynamic and functionally important network inside the nucleus. 
Therefore, studies of lamin interacting proteins will help us to better understand the nuclear 
structure and function. 
SW59, one of the alternative splicing isoforms of the lola locus, might interact with the 
kinase domain I of JIL-1 
Like any development process, the development of the central nervous system is 
regulated by genes expressed at the right time and place. Interfering with gene expression has 
profound effects on normal development. Mutations in the Drosophilci lola (longitudinal 
lacking) gene, which encodes putative transcription factors, cause severe defects in the 
development of the axon tracts of the central nervous system. In the embryos of a lola 
mutant, lola501, in which a P-element was inserted at the 5' end of the gene, the longitudinal 
tracts are broken at junctions of two adjacent segments and the two commissure tracts (cross 
tracts) of the same segment are fused with each other (Giniger et al., 1994). Two alternatively 
spliced RNA isoforms, lola long and lolci short, were initially reported (Giniger et al., 1994). 
The two Lola proteins derived from these two RNA isoforms share a common region of 454 
AAs (amino acids) including a conserved BTB domain (see below) and a NLS (nuclear 
localization sequence) (Fig 15A). Comparing the cDNA sequence with the genomic sequence 
of lola, we found that the two alternatively spliced isoforms share four exons, exon I, II, III, 
and IV, which encode the common part of the protein (Fig 15B). The starting methionine of 
the protein is contained in exon I. The most 5' exons of lola long and lola short are different: 
it is exon-5'altd in lola long and it is exon-5'altc in lola short (Fig 15B). Exon IV in lola long 
is 78bp and linked to a 45kb downstream exon, which encodes two zinc finger motifs. 
However, exon IV of lola short extends from the 78bp exon into adjacent downstream 
sequence including an early stop codon, therefore, the Lola short protein has only 467 AAs 
Fig 15. Lola protein isoforms and the genomic map of lola. (A) Alignment of protein 
sequences of Lola isoforms, including the published Lola short, Lola long, SW59, and the 
predicted Altl, 2, 3, 4, and 5. The length of each protein is labeled at the end. The shared 
region by all isoforms is indicated by a black box. The position of the two zinc finger motifs 
in Alt2-5, SW59, and Lola long is labeled. The part of the SW59 sequence contained in KDI-
J1 clone is underlined below SW59. All of alternatively spliced isoforms have a common N-
terminus including a BTB domain and a NLS (nuclear localization signal). Lola short and 
Altl contain the shared sequence (454 residues) and 13 additional amino acids but do not 
have a zinc finger motif. The exon IV of lola short and Alt lis extended from exon78 (a 78bp 
exon shared by all known isoforms and linked to unique zinc finger containing exons) into 
downstream sequence including an early stop codon. The sequence of the zinc finger motifs 
in lola long, SW59, and Alts are aligned at the bottom with the conserved residues labeled 
including the zinc binding residues. (B) A genomic map of lola with the known and predicted 
splicing isoforms. All splicing isoforms include exon I, II, III, and IV in their cDNAs, which 
encode the part of protein commonly shared. Alt2, 3, 4 and 5 were predicted to have different 
5' exons, 5'alta, 5'altb, 5'altc, and 5'altd, respectively, which use the same zinc finger 
encoding exon that is different from that in S W59 or Lola long. 
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and no zinc finger motifs. The phenotypes of lola mutants suggest it may regulate nervous 
system development. In agreement with this prediction, staining with a rabbit polyclonal 
antibody made against the shared region of Lola demonstrated that the protein was enriched 
in the nuclei of nervous system in later embryonic stages (Giniger et al., 1994). 
The Lola long protein has two zinc finger motifs of a C2HC type and a C2H2 type. 
The C2H2 type zinc finger was often found, while the C2HC type zinc finger is quite 
uncommon and has only been found in a small number of proteins, including the Drosophilci 
Su(Hw) (suppressor of hairy wing protein, Parkhurst et al., 1988) and snail (Boulay et al., 
1987). Each zinc finger motif has a conserved (3(3cx structure with the conserved C and H 
residues coordinately binding a zinc ion (Wolfe et al., 2000). The zinc finger usually 
functions as a motif that determines the DNA binding specificity of a protein. However, in 
some proteins, the C2H2 zinc finger can mediate RNA-protein, or protein-protein interaction, 
suggesting that the zinc finger motif may have diverse functions (Wolfe et al., 2000). 
The BTB domain shared by both the Lola long protein and the Lola short protein is a 
conserved domain with about 120 amino acids. It was so designated because this domain was 
originally found in Briac-à-brac, Tramtrack, and Broad-Complex. The crystal structure of the 
BTB domain from human PLZF (gromyelocytic leukemia zinc finger) protein indicated that 
this domain consists mainly of |3-sheets and a-helices and can form stable dimers by 
hydrophobic interactions (Ahmad et al., 1998). The BTB domain can mediate the formation 
of both homodimers and heterodimers and was estimated to present in 5-10% of human zinc 
finger containing proteins (Ahmad et al., 1998). 
Another lola isoform, SW59, was cloned in an enhancer trap screen looking for genes 
primarily expressed in the nervous system (Zhong, 1997; gene bank DNA sequence 
submission). The 5' end exon of SW59 is exon-5'altc, an alternative exon encoding a 5'UTR 
region and predicted by the Drosophila genome project (see below), and the 3' end exon of 
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SW59 is another zinc finger containing exon (Fig 15B). SW59 also contains the four-shared 
exons of lola long and lola short. The SW59 protein derived from the cDNA has 748 AAs 
with a region of 454 AAs shared with other Lola isoforms and a region of 294 AAs in its 
unique C-terminus (Fig 15A). Interestingly, the SW59 C-terminus also contains two zinc 
finger motifs of the C2HC type and the C2H2 type (Fig 15A). 
Additionally, another zinc finger containing exon was predicted by the fly genome 
project. In the genome annotation, five alternative splicing isoforms of lola, Altl, 2, 3, 4, and 
5, were predicted (Fig 15B). The Altl isoform is the same as lola short. Alt2, 3, 4, and 5 have 
different 5' exons, exon-5'alta, -5'altb, -5'altc, and -5'altd, respectively, but have the same 
coding sequences. Surprisingly, the predicted zinc finger containing exon by the genome 
project also has the C2HC type and the C2H2 type zinc finger motifs. The zinc finger motif 
sequences of Lola long, SW59, and Alt2-5 are aligned to show the conserved residues 
including the residues that contribute to zinc binding (Fig 15A). It is quite intriguing to us 
that neither the SW59 isoform nor the lola long isoform was predicted by the fly genome 
project, suggesting that the splicing pattern of lola is very complicated. 
Alternative splicing is a common phenomenon in higher eukaryotes and is considered 
as an important mechanism to greatly increase the number of proteins produced by a genome 
(Claverie, 2001; Graveley, 2001). It was surprising to many people that only about 30,000 
genes were found in the first version of human genome, which is much lower than the 
previously estimated 80,000 genes. Compared with the some 20,000 genes in C. elegans and 
some 13,000 genes in Drosophila, one might think the number of genes in human should be 
higher considering the complexity of human body and mental behaviors. However, the 
number of proteins produced by a genome is not solely determined by the number of genes. 
For example, the Drosophila DsCAM (Down syndrome cell adhesion molecule) gene could 
possibly produce as many as 38,000 different Ig domain containing cell adhesion proteins 
(Schmucker et al., 2000). Hence, the protein diversity can be greatly increased by alternative 
splicing. However, this is also a great challenge for finding out all of the protein products of 
a certain organism in the post-genome era (Black, 2000). 
To search for JIL-1 interacting proteins, the KDI (kinase domain I) of JIL-1 was used 
as a bait to screen a 0-18 hour Drosophila embryonic library. In this screen, we identified a 
clone, KDI-J1, which contains the C-terminal portion of the SW59, an alternative splicing 
isoform of the lola gene. The part of SW59 included in the KDI-JI clone is underlined in fig 
15A. 
To further investigate the putative interaction between JIL-1-KDI and the C-terminal 
domain of SW59, we generated a monoclonal antibody, 7FI, by immunizing mice with the 
GST-J1 fusion protein, which contains the unique SW59 C-terminus (294 AA) and about 28 
AA from the shared regions of all isoforms. On western blots, 7F1 recognized two proteins 
with molecular weights of about 110KD and 200KD, respectively. These two proteins are 
designated as 7F1-I00 and 7F1-200 in the following discussions. The expression of 7F1-200 
and 7F1-100 demonstrated a dynamic pattern during development (Fig 16). On a 
developmental western blot with samples collected every 5 hours after egg-laying, the 7F1-
100 protein was found to be expressed at a high level in the early embryos and then gradually 
reduced. After 20 hours of development, a time before the first instar larvae hatched out, the 
expression of 7F1-100 was detectable by western blot. In contrast, the 7F1-200 was 
transiently expressed in the early embryos, reduced in the 5-10 hour embryos and then 
expressed again at gradually increasing levels in the later developmental stages. The 
predicted molecular weight of SW59 is 117KD, which is very close to the 110KD molecular 
weight of 7F1-100. Therefore, the 7F1-100 protein is likely to be the protein predicted from 
the SW59 cDNA sequence. Then, what is this 7F1-200 protein? Several possibilities came 
into consideration: first, it could be an alternatively spliced isoform of lola containing an 
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Fig 16. Developmental western blot of the two proteins recognized by 7F1 mAb. The 7FI 
mAb can recognize two proteins: the one with a molecular weight about 200BCD is designated 
7F1-200; the one with a molecular weight about 110KD is designated 7F1-100. Samples 
were collected every 5 hours after egg-laying. Lane 1, 0-5 hour embryos; lane 2, 5-10 hour 
embryos; lane 3, 10-15 hour embryos; lane 4, 15-20 hour embryos; lane 5, 20-25 hour 
embryos and larvae; lane 6, first instar larvae; lane 7, third instar larvae. The 7F1-100 protein 
was expressed in the early developmental stages and disappeared in the 20-25 hour embryos. 
In contrast, the 7F1-200 protein had a transient expression in the early embryos, was nearly 
disappeared in the 5-10 hour embryos, then expressed and maintained at a high level in the 
later developmental stages. 
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epitope recognized by 7F1; second, it could be another unknown protein that was cross-
recognized by the 7F1 mAb. Right now, there is no convincing evidence to support either of 
these hypotheses. Future efforts to understand the molecular characteristics of this 7F1-200 
protein will be required. 
The yeast two-hybrid experiment suggested that there is putative interaction between 
the C-terminal part of SW59 and the KDI of JIL-1. In order to analyze this interaction, we 
carried out in vitro GST-pull down (GST-pd) experiments. The GST-J1 fusion protein, which 
contains the part of the SW59 sequence included in KDI-J1, was bound to agarose beads to 
do pull down experiments using the S2 cell lysate. As shown in the upper panel of fig 17A, 
the GST-J1 fusion protein could pull down JIL-1 but the GST protein alone could not. 
To answer whether 7F1-200 can interact with JIL-1, we have carried out in-vitro co-
IP (immunoprecipitation) assays. Since the 7F1-200 protein was detected by the 7F1 mAb in 
S2 cell lysate (Fig 17C), we performed co-IP experiments using the S2 cell lysate. Using 7F1 
for co-IP assays, JIL-1 was co-immunoprecipitated and detected on western blots by affinity 
purified JIL-1 Hope antibody. As a control, a monoclonal antibody, G39, recognizing the 
Gliarin protein in leech (Xu et al., 1999), was unable to co-IP JIL-1 (Fig 17A, middle panel). 
Conversely, the JIL-1 polyclonal antibody ODIN could co-IP 7F1-200 from S2 cell lysate but 
the PIRS (preimmune rabbit serum) could not (Fig 17A, bottom panel). These data supported 
that there is putative interaction between JIL-1 and 7F1-200. Since JIL-1 was found to be a 
part of the MSL (male specific lethal) dosage compensation complex (Jin et al., 2000; Fig 7), 
the immunocomplex of 7F1 mAb was also checked for the presence of MSL1 by western 
blot. Interestingly, MSL1 was also found to be in the immunocomplex of 7F1 mAb (Fig 17B, 
bottom panel). Conversely, when 7F1 was used on western blots to probe the 
immunocomplex of MSL1 antibody, the 7F1-200 protein was found to be 
coimmunoprecipitated by the MSL1 antibody (Fig 17B, upper panel). These data suggest that 
Fig 17. In vitro protein interaction studies. (A) Upper channel, the GST-J1 fusion protein 
containing the C-terminus of SW59 sequence was expressed in E. coli and bound to 
glutathione agarose beads for pull down experiments. The GST-J1 (GST-Jl-pd) could pull 
down JIL-1 as detected on western blots by an affinity purified JIL-1 antibody, Hope. In the 
control (GST-pd), the GST protein alone did not pull down JIL-1. In the middle panel, 7F1 
mAb (7F1 ip) made against J1 sequence was able to co-IP JIL-1 from S2 cell lysate as 
detected with the JIL-1 Hope antibody on western blots. As control (control ip), G39 mAb 
recognizing a leech protein, Gliarin, was unable to co-IP JIL-1 from S2 cell lysate. In the 
bottom panel, the anti-JILl polyclonal rabbit serum ODIN was able to co-IP 7F1-200 shown 
as a doublet bands on this gel. As control (control ip), normal rabbit serum could not co-IP 
7F1-200. (B) Upper panel, the MSL1 antibody (MSL1 ip) could co-IP the 7F1-200 protein as 
detected by 7F1 mAb on western blots. In the control (control ip), the normal rabbit serum 
could not co-IP 7F1-200. Bottom panel, conversely, 7F1 mAb (7F1 ip) was able to co-IP 
MSL1 as detected by MSL1 antibody on western blots. As control (control ip), G39 mAb 
was not able to co-IP MSL1. The lysate (S2 cell lysate) was used for western blots to indicate 
the size of each protein. (C) The 7F1-200 protein could be detected from both the S2 cell 
lysate (S2) and from the dissected salivary glands associated with fat bodies (SG and FB). 
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the 7F1-200 protein could possibly interact indirectly with components of the MSL complex 
by interacting with JIL-1 or even directly with other components of the MSL complex. 
In early embryos, 7F1 mAb can stain the nuclei of early embryos (Fig ISA) similarly 
as the Lola polyclonal antibody made against the common region of Lola (Giniger et al., 
1994). Since 7F1-200 was also expressed in salivary glands and/or fat bodies (Fig 17C). The 
7F1 mAb and JIL-1 antibody were used for double labeling on polytene chromosome 
squashes. The titer of 7F1 mAb tissue culture medium was not very high and the 7F1 staining 
signal on polytene chromosomes was not very strong. However, there are some discernible 
bands on the male X stained by 7F1 (Fig 18B). In the composite image, there is 
predominantly yellow signal on the male X chromosome, suggesting that 7F1-200 and JIL-1 
were colocalized on the male X (Fig 18D). The immunostaining data and the co-IP data 
further suggested that JEL-1 and the 7F1-200 protein may interact with each other. 
As discussed above, the splicing pattern of the lola locus seems to be very 
complicated. I was intrigued by the possible presence of more zinc finger containing exon(s) 
in the lola genomic region and did some bioinformatic analysis of the lola genomic DNA. 
There are about 45kb between exon IV (78bp long, referred as exon78 hereafter) shared by the 
known lola isoforms and the unique zinc finger encoding exon of lola long. There is another 
gene transcribed from the opposite direction not far downstream from the lola long 3' exon, 
suggesting that the lola long 3' exon is probably the 3' boundary of lola. Therefore, attention 
was focused on the 45kb region between the exon78 and the lola long 3' exon to look for 
alternative splicing. We searched for more putative zinc finger containing exons in this 
region by searching for the conserved pattern of zinc finger motifs. To do this, the genomic 
sequence of lola was translated into protein sequence in three open reading frames in the 
GCG program. Three consensus sequences of zinc finger motifs, CXXC ('X' stands for any 
residues), HXXXXC, and HXXXXH, were used to search the predicted peptide sequence. If 
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Fig 18. Immunostaining with 7F1 mAb and JIL-1 antibody. (A) The 7F1 mAb stains the 
early embryo nuclei (white signal). (B, C, and D) Double labeling of male polytene 
chromosomes with 7F1 mAb and JTL-l antibody. The 7F1 staining is not very strong but has 
some discernible bands on the male X chromosome (B) The JTL-l protein is found to form 
many bands on the male X chromosome. (C) In the composite fig D, the predominant yellow 
signal on the male X chromosome suggesting the overlaps between 7F1 staining and JTL-l 
staining. 
a region with a long continuous coding sequence (without a stop codon) contains the CXXC, 
HXXXXC, and HXXXXH sequences, it was considered as a putative zinc finger encoding 
exon. In addition, the distance between the second C and the first H in a zinc finger motif is 
usually 12 residues, which offers a standard to judge whether the adjacent CXXC sequence 
and the HXXXXC/HXXXXH sequence are included in the same zinc finger. This analysis 
was done in the Microsoft word'98 program using the "find" function. In the first round of 
searching, there were thirteen putative zinc finger-containing exons identified, which were 
numbered from 1 to 13, including lola long (13), SW59 (5), and the exon predicted by the 
genome project (9). Reading through the sequence line by line by eye, two more putative 
zinc finger containing exons were found and designated as 10.5 and 12.5 because they were 
between 10 and 11, 12 and 13, respectively (Fig 19). Fig 20 is a clustalw alignment of the 
zinc finger sequences, in which the conserved zinc binding residues are red-colored. The zinc 
finger regions of exon 8 and 13 have very high identity, suggesting that they could recognize 
very similar DNA binding sequence. More interestingly, thirteen of the fifteen predicted 
exons contain sequence encoding two zinc finger motifs of the C2HC type and the C2H2 (or 
C2HC, number 10) type (Fig 20). Note the C2HC type zinc finger was not often found, 
therefore, the finding of so many putative C2HC type zinc fingers in the lola genome is quite 
unusual. The other two, number 4 and 12.5, have sequence to encode only one C2H2 type 
zinc finger. Another fascinating question is whether these putative exons are used for 
alternative splicing, i.e., if they were exons, they should be included in mRNA sequence. To 
analyze this question, the 45kb genomic sequence of lola gene was first used to search for 
EST sequences using the GenSequer program developed by Dr. V. Brandel's lab. We found 
fifteen clusters of EST sequences in the 45kb genomic region, suggesting that the presence of 
multiple alternative splicing isoforms in this region is likely (Fig 19, top line). Since the zinc 
finger encoding exons of lola long, S W59, and alt2-5 are spliced to the 5' exon78, we 
Fig 19. The genomic map of the lola locus. The top line is the clusters of EST (expression sequence lag) identified in the 
GenSequer program, which were labeled by black boxes. The predicted putative zinc finger containing exons were numbered and 
shown on the second line with black boxes. PGR and EST evidence supported ten out of the fifteen putative zinc finger encoding 
domains were used as exons and joined with the exon78, which were shown in this figure by linking the putative exon with exon78. 
PCR evidence exists for 1, 2, 6, 9, 11, and 12.5. EST evidence exists for 3 (LD03274), 5 (SW59, LD31218, LD33478), 8 
(LD29668), and 12.5 (LD14150). 
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2 . GKLQCPQCPNAYTRLSALKRHLEFECG—MLENFRCQVCDAGFKR—KDSLNRHCKVKKHNRKY 60 
7. NSHICPRCEKAYTYKKNLSRHLRYECG QLPTEKCRHCSYVARY--KHSLNMHVKTQHPEQI 59 
6. YQHACDQCGKSYKTRKSLSRHRRFECRFTTERPIFQCPSCNYAAKR--SDNLTKHIKTHFAKM 61 
10.5 GAYACDRCGNTYARPHSLNRHVRFECG—VEPKFECPICHKKSKH—KHNLVLHMRTHQHR 57 
12. CKYACNVCGKTYKIKGSLKRHKNYECG VEPNLKC PHC PHKCKY--RSDLRKHMNQKHADSG 59 
8. SRYVCRHCGKKYRWKSTLRRHENVECGG--KEPCHPC PYC SYKAKQ--RGNLGVHVRKHHPEKP 60 
13. PVYECRHCGKKYRWKSTLRRHENVECGG--KEPSHQCPYCPYKSKQ--RGNLGVHVRKHHTDLP 60 long 
9. AGHPCPVCGRVYKLKSSLRNHWKWECG KEPQFQCPFCVYRAKQ--KMHIGRHMERMHKEKF 59 
I. APFVCQTCGRRYQVLGTLRRHMRKECNQ PKKYVCRMCERRFHY--NFKLQDHYYYVHKGVQ 59 
3. ESFTCPQCYRTYRRHGTLRRHLRQECGK GKSMVCSVCGHRTKR--ADHLRQHVRKKHPEIA 59 
II. SFMQCKHCNRYYKSHQKLQEHVRKYCLK---QKKYKCVSCEYRSRR--KDHVLRHAKRKHCMLY 59 
12.5 ESNRCPLCSRVCRS--QAFLNEHMRKEHSVLI 33 
4. VQFHCEFCNFSCSWR--YDLKLHLRQKHGIHQ 33 
5. ERFHCAVCNKSYLRKRHLQRHMRDECIG--IPPRFNCEFCCSRFRR--KYHMVRHLVSKHGIPA 60 SW59 
10. KPWVCRNCNRTYKWKNSLKCHLKNECG LPPRYFCSKMCG-YATNVHSNLKRHLNTKCRDRE 10 
Fig 20. Clustalw alignment of the 15 putative zinc finger (number 1-13, and number 10.5 and 12.5) encoding sequences in the 
lola locus. Thirteen of them contain two putative zinc finger motifs of a C2HC and a C2H2 (or C2HC in number 10) type. Two 
of them have only one putative zinc motif (number 4 and 12.5) of a C2H2 type. Notice that the sequence of number 8 and 13 
are very similar with each other. The conserved C and H residues that bind a zinc ion were red-colored. 
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predicted that all the putative zinc finger encoding exons can be possibly spliced with the 
exon78. Based on this prediction, we designed 13 pairs of primers for PCR to analyze whether 
these putative zinc finger containing exons are used for alternative splicing. The SW59 and 
lola long were not included for designing primers because their cDNA sequences have been 
previously reported. The 5' primer was designed in the exon78, which is the same for all of 
the primer pairs. The 3' primers were designed around the first stop codon of each of the 
putative zinc finger coding exons and are different from each other. PCR was done with 
plasmids isolated from a 0-18 hour Drosophila yeast two-hybrid library, which contains the 
cDNA of 0-18 hour embryos. The PCR results showed that number 1,2,6,9, 11, 12.5 exons 
were possibly spliced with the exon78, which was confirmed by cloning and sequencing the 
PCR products. In addition to the PCR method, we have acquired EST (expression sequence 
tag) clones of the lola locus from the fly EST stock center. Sequencing these EST clones 
with a primer in exon78, number 3 and 8 exons were found to be alternatively spliced to 
encode mRNAs. Taken together, the presence of 10 different alternatively spliced zinc finger 
exons has been confirmed. 8 of them were found in this study (Fig 19). It is interesting to 
note that the zinc finger motif is important to determine the DNA binding specificity of these 
Lola isoforms. Therefore, different Lola isoform can have different DNA binding specificity 
and regulate different gene(s). However, whether the other five putative zinc finger 
containing exons, number 4, 7, 10, 1 land 12, are used for alternative splicing still requires 
further study. 
In conclusion, the yeast two-hybrid study with the KDI of JDL-1 led our interest to the 
lola gene. Intrigued by the complicated splicing pattern of lola, we have examined the lola 
locus for putative alternative splicing. The existence of at least 10 different zinc finger 
coding exons from this single gene again stressed that protein diversity can be greatly 
increased by the alternative splicing mechanism (Claverie, 2001; Graveley, 2001). The 
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enigmatic 7F1-200 protein can possibly interact with JIL-1 but its molecular nature is still 
unknown, which needs further study. 
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CHAPTER 5. CONCLUSIONS 
JIL-1 mediates histone H3 SerlO phosphorylation 
The JIL-1 Ser/Thr kinase has high homology with members of the MSK and RSK 
subfamilies, which are found to be involved in the H3 SerlO phosphorylation signal 
transduction pathway in mammalian systems (Sassone-Corsi, et al., 1999; Thomson et al., 
1999b). The phosphorylation of H3 SerlO in combination with the acetylation at adjacent 
lysine residues likely defines the histone code deciphered by component(s) of the 
transcription complex for gene expression (Cheung et al., 2000b; Clayton et al., 2000). 
Furthermore, the H3 phosphorylation is also correlated with chromosome condensation and 
segregation. For example, when the SerlO phosphorylation is prevented by a S10A 
substitution in Tetrahymena, normal mitotic chromosome segregation behavior is perturbed 
(Wei et al., 1999). Therefore, the effect of SerlO phosphorylation is context dependent, i.e., is 
determined by other modifications of adjacent histone residues and/or by proteins that 
recognize the phosphorylated SerlO. 
The in-vitro and in-vivo data strongly suggest that JIL-1 is involved in a signal 
transduction pathway leading to H3 SerlO phosphorylation. In the in-vitro immunocomplex 
kinase assays, the JIL-1 immunocomplex was able to phosphorylate histone H3, showing 
preference to the SerlO site in a synthetic peptide (Fig 6). In vivo, the SerlO phosphorylated 
H3 isoform was elevated on the male X chromosome and colocalized with JIL-1 (Fig 12). In 
addition, the H3S10 phosphorylation level is greatly reduced in the third instar larvae of JIL-
1 mutant animals, which is mostly comprised of interphase cells. The levels of reduction are 
correlated with the decreased levels of JIL-1 protein in the mutants. Moreover, the reduced 
pH3S10 level in the JIL-1 null Z2 can be restored by the introduction of a GFP-JIL-1 
transgene. 
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In many species, there are two enzymatic systems controlling H3 SerlO 
phosphorylation during interphase and during mitosis, respectively. We found that mitotic 
H3 SerlO phosphorylation was present in the JIL-1 null mutant Z2, therefore, JIL-1 is likely 
to be mainly involved in the interphase H3S10 phosphorylation pathway. Furthermore, 
because H3S10 phosphorylation level is reduced to about 5% in the third instar larvae of JIL-
1 null Z2, we reasoned that the JIL-1 pathway is the predominant interphase H3S10 
phosphorylation pathway. 
JIL-1 is required for maintaining higher order chromatin structure 
In the JIL-1 strong hypomorph Z60 and null Z2, where the JIL-1 protein level is very 
low, or reduced to zero, the higher order polytene chromosome structure is severely 
perturbed (Fig 10). Generally, the chromosome arms in JIL-1 mutants are shorter and broader 
compared with those of wild type. The Hoechst and MSL2 antibody stained banding pattern 
has largely disappeared. The female X chromosome was affected to the same level as the 
autosomes. In contrast, the male X chromosome demonstrates higher sensitivity to the 
decreased level of JIL-1 protein, forming a structure that totally lost the Hoechst and MSL2 
staining pattern, suggesting the open male X chromosome is more sensitive to the levels of 
JIL-1 protein reduction. 
In the JIL-1 mutant embryos produced by the homozygous EP3 parents, the rapidly 
replicating and dividing chromosomes demonstrate various distorted morphologies. The 
chromosomes in these EP3 embryos were often disintegrated and fragmented, forming 
clumps. Abnormal microtubule spindles sometimes form on the chromosome remnants in the 
mutant embryos (Fig 9). Therefore, it seems likely that the loss of JIL-1 can lead to the 
disruption of both interphase chromatin structure and mitotic chromosome integrity. How 
could the partial loss of JIL-1 function lead to the formation of these abnormal 
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chromosome/chromatin structures and mitotic defects? One hypothesis is that the mitotic 
defects observed are a consequence of abnormal interphase chromosome structure. However, 
since JIL-1 is associated with the mitotic chromosomes during M phase, other mitotic 
function of JIL-1 might exist besides its interphase function. 
The finding that the structure of all of the chromosomes, including that of male X 
chromosome and autosomes, is affected in the JIL-1 mutants, suggests that JIL-1 plays a 
more general role apart from its putative function on the male X chromosome for dosage 
compensation. This observation is in agreement with the global distribution of J IL-1, i.e., not 
only elevated on male X chromosome, but also present on the male autosomes and 
distributed evenly on all of the female chromosomes. 
JTL-1 plays a putative role in dosage compensation 
Previous studies have shown that the level of JIL-1 protein is increased on the male X 
chromosome and that JIL-1 is colocalized with MSL (male specific lethal) proteins on the 
male X chromosome (Fig 4; Jin et al., 1999). Furthermore, the in vitro protein-protein 
interaction studies demonstrated there was physical interaction between JIL-1 and 
components of the MSL dosage compensation complex (Fig 7; Jin et al., 2000), suggesting 
that JIL-1 may be involved in dosage compensation. 
By analyzing and comparing the viability of male and female JIL-1 mutants, we 
found that the viability of both males and females was reduced in the mutant strains, 
suggesting JIL-1 has a general function that is required by both sexes (Table l; Wang et al., 
2001). We also found that, of the surviving homozygous JIL-1 progeny, females outnumber 
males, suggesting that JIL-1 may also play a role in the dosage compensation pathway. This 
male super sensitivity to JIL-1 function is consistent with the elevated JIL-1 levels on the 
male X chromosome and the concomitant intensified H3S10 phosphorylation levels on the 
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male X chromosome (Fig 12). The fact that JIL-1 is essential for the viability of both males 
and females also explains why JIL-1 was not identified in previous genetic screens looking 
for a male specific lethal phenotype. 
Taking the above three conclusions together, we propose a model that the JIL-1 
kinase is involved in a signal transduction pathway that regulates H3 S10 phosphorylation in 
interphase, which is required for maintaining higher order chromatin structure, and is 
involved in the dosage compensation pathway. However, the above model does not rule out 
that JIL-1 may be involved in other signal transduction pathways and can mediate 
phosphorylation of other substrates. 
The lola gene locus has a complicated alternative splicing pattern 
In the effort to find JIL-1 interacting proteins using the yeast two-hybrid method, an 
alternative splicing isoform of the lola gene, SW59, was identified. Lola gene encodes 
transcription factors with zinc finger motifs, which was reported to regulate nervous system 
development in early embryos (Giniger et al., 1994). In addition to studying the putative 
interaction between SW59 and JIL-1, we have found that this gene has a very complicated 
splicing pattern. Detailed analyses of the genomic sequence of this gene found there are at 
least fifteen putative zinc finger encoding exons. Thirteen out of the fifteen putative zinc 
finger exons can encode two zinc finger motifs of the C2HC type and the C2H2 type. The 
remaining two have conserved sequences for one C2H2 type zinc finger. Using PCR method 
and sequencing EST clones of the lola gene, we found ten out of these fifteen predicted zinc 
finger exons are actually used for alternative splicing. This suggests that at least ten different 
zinc finger proteins can be produced from the lola gene by alternative splicing. Since zinc 
fingers can determine the DNA binding specificity of the proteins, these proteins will each 
have different recognition sequences in terms of DNA binding. The implication of this 
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finding and other studies of alternative splicing (Schmucker et al., 2000) is that the number 
of proteins produced by the genome might be much higher than the number of genes. This 
has raised another important task for the post genomic era, which is to identify all the 
transcripts produced by a genome. 
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APPENDIX A. PRIMERS 
name Sequence (5'-3') description 
JFU (YJ3564) GAGTCACTAGCCTACGAG Nucleotide 1098-11131 of JIL-1 cDNA. used for 
GTACCAGATCAAATG 
making a Kpnl site at JIL-1 N-terminus 
JFL (YJ3562) GGAAATCAAGGAGGTACC Nucleotide 4670-4688 of JIL-l cDNA, used for 
GCGAAAGGAGG 
making a Kpnl site at JIL-1 C-terminus 
Sbstb (YJ3563) CATCACGAGCTACGAAAG Nucleotide 3507-3579 of JIL-l cDNA, used as 
CGAATG 
selection primer for mutagenesis 
7A6A (YW1891) GGTTCAAAAAAGCGCGTC Nucleotide 4432-4450 of JIL-1 cDNA. used to 
make a 7A to 6A mutagenesis in JIL-1 cDNA 
Seq 1 (WY3879) TGTGGTAGCACGCATTCC Nucleotide 2444-2462 of JIL-1 cDNA, used for 
sequencing 
PKPNT (YW4127) AATTCGACGGTACCATCG For generating a Kpnl site in pGex4T-3 
THNP5 (YW5338) TCGAATTCATGAGTCGCT Nucleotide 1011-1032 of JIL-1 cDNA. the 5' primer 
TGCAAAAGCA 
for two hybrid construct BD-NTD 
THNP3 (YW5337) GACCCGGGGAGAACGCGT Nucleotide 1796-1892 of JIL-1 cDNA, the 3' primer 
ATTATTTTGAA 
for two hybrid construct BD-NTD 
THCP5 (YW5335) T GGAATT C AT GCACGACA Nucleotide 3787-3811 of JIL-l cDNA, the 5* primer 
AGTCGGC 
for two hybrid construct BD-CTD 
THCP3 (YW5336) GAGT C GACAT GT CAT T GG Nucleotide 4616-4634 of JIL-1 cDNA, the 3' primer 
AACTGATAAAG 
for two hybrid construct BD-CTD 
PBD5S (YW5884) GT GCGACAT CAT CAT CGG 5' sequencing primer for the pBD vector of 
AAG 
Stratagen 
PAD5S (YW6782) AGGGATGTTTAATACCAC 5' sequencing primer for the pAD vector of 
TAC 
Stratagen 
DESC3P (YW7375) CCGCGGCCGCCTTGGAAC Nucleotide 4611-4637 of JIL-1 cDNA, the stop 
TGATAAAGTTGACG 
codon is mutated to express JIL-1 -V5 in S2 cells 
PMETS (YWl 163) GTGGTCTTGCTGCTGCTA Nucleotide 1329-1341 of JIL-1 cDNA, used for 
TTG 
sequencing 
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KD1TH5 (YW2667) CCGAATTCTACAGTGATG Nucleotide 1754-1778 of JIL-1 cDNA, the 5' primer 
AGGCCGTT 
for two hybrid construct BD-KDI 
KDITH3 (YW2666) AGTTGTCGACGGCGGTGA Nucleotide 2657-2670 of JIL-1 cDNA, the 3' primer 
GGGTG 
for two hybrid construct BD-KDI 
KD2TH5 (YW2665) TGAAATTCCAGAATATAC Nucleotide 2851-2872 of JIL-1 cDNA, the 5' primer 
CTTGTCGGCCAG 
for two hybrid construct BD-KDH 
KD2TH3 (YW2664) GTACCCGGGCCGTCAGTT Nucleotide 3741-3760 of JIL-1 cDNA, the 3' primer 
GTTCCATAGT 
for two hybrid construct BD-KDH 
DHIP5 (YW2864) CGAATTCATGTCTGATTC 5' primer to clone fly histone HI from genomic 
TGCAGTTG 
DNA by PCR 
DH1P3 (YW2865) AAGCGTCGACCTTTTTGG 3' primer to clone fly histone HI from genomic 
CAGCCGTAGTCTT 
DNA by PCR 
DH2A5 (YW2866) CGAATTCATGTCTGGACG 5* primer to clone fly histone H2A from genomic 
TGGAAAA 
DNA by PCR 
DH2A3 (YW2867) AACGGTCGACGGCCTTCT 3' primer to clone fly histone H2A from genomic 
TCTTCGGTCTT 
DNA by PCR 
DH285 (YW2868) CGAATTCATGCCTCCGAA 5* primer to clone fly histone H2B from genomic 
AACTAGTG 
DNA by PCR 
DH2B3 (YW2869) AGGTGTCGACTTTAGAGC 3' primer to clone fly histone H2B from genomic 
TGGTGTACTTGGTG 
DNA by PCR 
DH3P5 (YW2870) TGAATTCATGGCTCGTAC 5' primer to clone fly histone H3 from genomic 
CAAGCAAACT 
DNA by PCR 
DH3P5 (YW2871) AACCGTCGACAGCACGCT 3' primer to clone fly histone H3 from genomic 
CGCCACGAATG 
DNA by PCR 
DH4P5 (YV/2872) AGAATTCATGACTGGTCG 5' primer to clone fly histone H4 from genomic 
TGGTAAA 
DNA by PCR 
DH4P3 (YW2873) AACCGTCGACACCGCCAA 3' primer to clone fly histone H4 from genomic 
ATCCGTAGAG 
DNA by PCR 
Pry4 (YW0683) CAATCATATCGCTGTCTC 
ACTCA 
A primer in the 3' of EP element 
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3'pGex (YW0968) CCGGGAGCTGCATGTGTC 
AGAGG 
5'pGex (YW0969) GGGCTGGCAAGCCACGTT 
TGGTG 
ACT5P (YW6402) TACCCATACGATGTTCCA 
GA 
BVJIL3 (YW0333) TCCCCCGGGATGTCATTG 
GAACT GAT AAAG 
3' sequencing primer of the pGex vectors (GST 
fusion protein expression) 
5' sequencing primer of the pGex vectors (GST 
fusion protein expression) 
5' sequencing primer of the pACT vector (two-
hybrid vector of Clontech) 
Nucleotide 4617-4638 of JIL-1 cDNA, used to 
clone JIL-l into the baculovirus vector 
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APPENDIX B. SELECTED CONSTRUCTS 
GST-JIL-1 GST-JEL-l fusion protein include residues 34-1207 of JIL-1 in pGex4T-3 vector 
GST-NTD GST fusion protein of the N-terminal domain of JIL-l, including residues 1-182 
GST-KDI GST fusion protein of the kinase domain I of JIL-l, including residues 213-520 
GST-KDII GST fusion protein of the kinase domain II of JIL-1, including residues 580-880 
GST-CTD GST fusion protein of the C-terminal domain of JIL-1, including residues 893-1207 
BD-NTD Two hybrid construct of the N-terminal domain with Gal4-DNA binding domain, 
including residues 1-182 of JIL-1 
BD-KDI Two hybrid construct of the kinase domain I with Gal4-DNA binding domain, including 
residues 213-520 of J IL-1 
BD-KDH Two hybrid construct of the kinase domain II with Gal4-DNA binding domain, including 
residues 580-880 of JIL-1 
BD-CTD Two hybrid construct of the C-terminal domain with Gal4-DNA binding domain, 
including residues 893-1207 of JIL-1 
GST-HI GST fusion protein of Drosophila histone HI 
GST-H2A GST fusion protein of Drosophila histone H2A 
GST-H2B GST fusion protein of Drosophila histone H2B 
GST-H3 GST fusion protein of Drosophila histone H3 
GST-H4 GST fusion protein of Drosophila histone H4 
GST-JI GST fusion protein of the C-terminal domain of SW59, including residues 426-748 
JIL-1-V5 JIL-1-V5 fusion protein to express in S2 cells, including residues 34-1207 of JIL-1 
BV-JIL-1 GST-JIL-l fusion protein construct to express JIL-1 in baculovirus system, including 
residues 34-1207 of JIL-1 
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